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 CORTICOTROPIN RELEASING FACTOR RECEPTORS AND AGONISTIC BEHAVIOR 
IN SYRIAN HAMSTERS 
by 
ALICIA N. FARUZZI 
Under the Direction of Kim L. Huhman, PhD 
ABSTRACT 
Social conflict is a part of everyday life, and it can be a potent stressor for both 
humans and other animals.  In the laboratory, when two Syrian hamsters (Mesocricetus 
auratus) compete for territory, a dominance hierarchy is quickly formed.  Becoming 
subordinate is a significant stressor resulting in increased release of adrenocorticotropic 
hormone, β-endorphin, and cortisol.  Defeated hamsters will also subsequently fail to display 
territorial aggression in future social encounters and will instead display increased 
submissive behavior, even in the presence of a smaller, non-aggressive intruder.  This change 
in behavior is consistent and long-lasting and has been termed conditioned defeat (CD).   
Corticotropin releasing factor (CRF) is an important neuropeptide in the control of the 
hypothalamo-pituitary-adrenal (HPA) axis response to stress.  It is also involved in a number 
of behaviors such as anxiety, stress responding, food intake, learning, and memory.  The 
widespread distribution of CRF, CRF-like peptides, and CRF receptors, particularly in brain 
sites related to anxiety, fear, and stress responses, suggests a role for CRF and CRF-like 
peptides in modulating emotional responses other than via HPA axis activity.   
It has also been shown that CRF may have a role in the acquisition and expression of 
CD.  Non-specific and CRF type 2-specific CRF antagonists reduce the acquisition and 
expression of CD in male hamsters while injection of a CRF type 1-specific antagonist does 
  
not.  Therefore, the goal of this dissertation was to investigate the role of CRF type 1 and 2 
receptors in CD in hamsters and to identify neuroanatomical locations where CRF may be 
acting.  It was found that non-specific or CRF type 1 receptor specific agonists enhance the 
expression, but not acquisition, of CD.  Further, these agonists appear to enhance aggressive 
behavior in animals that were not previously defeated, suggesting a modulatory role for CRF 
type 1 receptors in agonistic behavior that depends on an animal’s previous social 
experience.  Further, localization of CRF receptors was determined in hamster brain in sites 
thought important for CD and agonistic behavior, but changes in receptor binding following 
defeat were not observed.  Implications of these results and future directions are discussed. 
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INTRODUCTION 
 This dissertation examines the role of corticotropin releasing factor receptors in 
agonistic behavior and in conditioned defeat in Syrian hamsters.  Data from a number of 
research areas including stress, anxiety, conditioned and unconditioned fear, aggression, and 
defense are relevant to this topic.  These areas are reviewed briefly in the following sections.  
Background material necessary for an understanding of corticotropin releasing factor and its 
receptors, both on a molecular level and as a modulator of behavior, are also presented.   
Stress 
Stress is the nonspecific response of the body to any demand, particularly one that is 
noxious (Selye, 1998).  The body has a given set of responses that it uses to deal with various 
stressors, and prolonged or severe stress can cause illness (Selye, 1979).  Stressful life events 
are linked to an increased chance of developing several psychological disorders, including 
affective or anxiety disorders (Holsboer, 1988; Barden, 1996; Plotsky et al., 1998; Mitchell, 
1998; Arborelius et al., 1999). 
Numerous animal models have been utilized to study stress, such as restraint, foot 
shock and forced swim.  However, many of these models use physical, sometimes painful, 
stimuli to evoke stress.  Although these studies have provided important insights into the 
physiological basis of stress, they may not be considered ethologically valid models of 
psychological stress.  For example, foot shock is not a stressor that an animal is likely to 
encounter in the wild, thus it may elicit a stress response that is much stronger than would be 
elicited in response to a more naturalistic stressor.  In contrast, a more relevant stressor, such 
as social conflict or predation, which an animal might encounter in the wild, may elicit a 
more natural stress response.  Some  
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current, more ethologically valid models of stress include features like maternal deprivation 
(Arborelius et al., 1999; Lehmann et al., 1999; Hsu et al., 2003; Romeo et al., 2003; Vazquez 
et al., 2003) or social interaction or conflict (Korte et al., 1990; Haller et al., 1996; Blanchard 
et al., 2001; Cacho et al., 2003; Summers et al., 2003). 
Social conflict is necessary for the development of social relationships in many 
species, both human and non-human.  When conflict arises, the outcome (i.e., whether the 
individual “wins” or “loses”) may have a strong and lasting impact.  Animals can encounter 
social conflict in such contexts as competition for food or access to females or territories.  
Results of being defeated during an agonistic encounter can include increased heart rate, 
elevated blood pressure, and suppressed immune function (Bohus et al., 1993; Blanchard et 
al., 1995; Meehan et al., 1995), as well as activation of the HPA axis and behavioral changes 
like decreased reproductive, exploratory, or aggressive behavior, decreased food and water 
intake, and increased anxiety (Heinrichs et al., 1992; Potegal et al., 1993; Rodgers and Cole, 
1993; Albonetti and Farabollini, 1994).   
Conditioned and Unconditioned Fear 
There has been extensive research investigating the neuroanatomy of fear, the control 
of which appears to lie in the amygdala or BST.  Several subnuclei of the amygdala appear to 
be critical components of the circuitry in the brain responsible for the acquisition and the 
expression of conditioned fear (Davis, 1997).  The BLA receives information from cortical 
areas involved in processing sensory input.  The BLA projects to the Ce which then projects 
to sites in the hypothalamus and brain stem that are responsible for mediating physiological 
and behavioral responses to stressors.  Some of these nuclei and their corresponding 
functions include the lateral hypothalamus (activation of the sympathetic nervous system), 
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the paraventricular nucleus (glucocorticoid release), the ventral tegmental area, locus 
coeruleus and basal forebrain (increased attention and vigilance), and the PAG (freezing or 
fleeing).  The amygdala also shares reciprocal projections with the BST, forming what is 
sometimes referred to as the extended amygdala (McDonald, 2003).  
Whereas the Ce is responsible for controlling conditioned fear responses via its 
projections to the hypothalamus and brainstem, the BST, or more specifically the lateral BST 
(BSTL), appears to be more involved in controlling the various physiological and behavioral 
responses to unconditioned fearful stimuli (Walker and Davis, 1997; Davis, 1997; Lang et 
al., 2000).  The BSTL receives input from the BLA and has similar outputs as the Ce (Davis 
and Shi, 1999).  Lesions of the BST block unconditioned fear responses in models such as 
light- or CRF-enhanced startle in rats but do not block fear-potentiated startle, a measure of 
conditioned fear.  Conversely, lesions of the Ce block fear-potentiated startle but not light- or 
CRF-enhanced startle.  Finally, inactivation of the BLA attenuates both types of fear 
responses.  These findings have supported the hypothesis that there are two central fear 
circuits, one for conditioned fear that is mediated by the Ce and one for unconditioned fear 
that is mediated by the BSTL (Walker and Davis, 1997; Davis and Shi, 1999).  
The Neurobiology of Agonistic Behavior 
Agonistic behavior refers to the profile of behaviors exhibited during social conflict.  
It includes aggressive behaviors, such as threat, attack, and pursuit, as well as defensive and 
submissive behaviors such as defensive postures and flight (Albers et al., 2002).  Social 
communication is another aspect of agonistic behavior, but the neurobiology of 
communicative behavior will not be discussed here.   
  
4
There are similarities and differences in the neural correlates controlling aggressive 
and defensive behavior.  The hypothalamus appears to lie at the center of either system 
(Delville et al., 2000; Canteras, 2002).  In the control of offensive aggression, the AH 
receives olfactory and vomeronasal inputs from the amygdala (Me) and BST, as well as 
somatosensory inputs from the PAG and autonomic inputs from the parabrachial nucleus 
(Delville et al., 2000).  These sites, as well as the LS, share reciprocal connections with the 
AH, and some of them show Fos activation following bouts of offensive aggression 
(particularly Me, BST, and PAG, and, of course, the AH).  The VLH also shows Fos 
activation and shares reciprocal connections with the AH, and stimulation of the VLH elicits 
offensive aggressive behaviors (Delville et al., 2000).   
The AH and the VMH are also important components of what Canteras (2002) refers 
to as the medial hypothalamic defense system, or MHZ.  Further, many of the same inputs 
important for aggressive behavior are involved in the control of defensive behavior, and most 
of these sites also show neuronal activation following social defeat (Kollack-Walker and 
Newman, 1995; Kollack-Walker et al., 1997; Martinez et al., 1998; Martinez et al., 2002).  
For example, the AH and VMHM receive inputs from the amygdala and BST that convey 
sensory information necessary to trigger innate defensive responses, while the parabrachial 
nucleus conveys information to the AH and VMHM about noxious stimuli (Canteras, 2002).  
The role of the LS is likely similar in both offensive and defensive behavior.  Specifically, 
the LS appears to exert inhibitory control over the initiation of aggressive behavior from the 
AH (Canteras, 2002).  While this reciprocal pathway may be more important for receiving 
feedback during offensive behavior (Delville et al., 2000), it would be important to have a 
direct pathway for inhibiting aggression when defensive behavior is the appropriate response.  
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Thus, the LS may act as a “switch,” turning attack on during offensive aggression or turning 
it off to allow for defense.   
Most outputs of the MHZ are to the same regions from where the inputs originate, 
likely forming feedback loops (with the LS, amygdala, and BST, specifically).  However, the 
VMHM projects to the PAG to organize defensive responses.  Additionally, the AH and 
VMHM both project to the dorsomedial hypothalamus, which coordinates behavioral, 
autonomic, and endocrine responses to acute stress (Canteras, 2002).  At this point, defensive 
and aggressive control differs greatly, because the stress response is an important element of 
defensive behavior.  Activation is seen in key sites involved in the stress response following 
acute defeat (Kollack-Walker and Newman, 1995; Kollack-Walker et al., 1997; Martinez et 
al., 1998; Martinez et al., 2002), making stress circuitry a critical component of the 
neurocircuitry controlling defensive behavior.   
Corticotropin Releasing Factor and its Receptors 
 CRF is a 41-amino acid peptide (Vale et al., 1983) located in the anterior pituitary 
and throughout the brain (Chappell et al., 1986; Eckart et al., 1999; Eckart et al., 2002).  
There are a number of peptides in the CRF family (see below), and they are involved in a 
range of behaviors such as anxiety, stress responding, food intake, and learning/memory 
(Eckart et al., 1999; Reyes et al., 2001; Grammatopoulos and Chrousos, 2002).  There are 
currently two known receptors in the CRF family.  CRFR1 has one functional splice variant 
and CRFR2 has three functional splice variants (CRFR2α,2β,2γ) (Dautzenberg and Hauger, 
2002; Eckart et al., 2002).  Both receptors are primarily Gs protein-coupled and they activate 
adenylyl cyclase to increase cyclic AMP levels, though they are also associated with other 
signaling pathways (Dautzenberg and Hauger, 2002; Eckart et al., 2002; Grammatopoulos 
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and Chrousos, 2002).  CRFR1 is found throughout the brain in areas important for sensory 
information processing and motor control, while CRFR2 is more restricted to subcortical 
regions (Reul and Holsboer, 2002).  CRFR1 mRNA has been found in sites including the 
anterior pituitary, cerebral cortex, cerebellum, amygdala, hippocampal formation, 
hypothalamus, areas of the brain stem, septum, BST, and olfactory bulb.  CRFR2 mRNA has 
been found in areas including the hippocampal formation, amygdala, LS, BST and areas of 
the hypothalamus and brainstem (Eckart et al., 1999; Bittencourt and Sawchenko, 2000; 
Dautzenberg and Hauger, 2002).  Binding of agonists to CRFR1 causes HPA axis activation, 
increased anxiety, increased depression, decreased feeding, and decreased inflammatory 
response; binding of agonists to CRFR2 causes decreased feeding, decreased gastric 
emptying, decreased depression (except when administered into the LS), increased 
vasodilation, and decreased blood pressure (Holsboer, 1999; Steckler and Holsboer, 1999; 
Arborelius et al., 1999; Eckart et al., 1999; Koob and Heinrichs, 1999; Takahashi, 2001; 
Dautzenberg and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002).  
The role that CRFR2 plays in anxiety and stress is not well understood.  Some studies and 
reviews report anxiolytic responses to CRFR2 activation (Eckart et al., 1999; Hashimoto et 
al., 2001; Dautzenberg and Hauger, 2002; Pelleymounter et al., 2002), while other studies 
report anxiolytic responses with antagonism of CRFR2 (Takahashi et al., 2001) or suggest 
that CRFR2 activity can produce anxiogenic or anxiolytic properties depending on when 
testing occurs or where in the brain the receptors are activated (Reul and Holsboer, 2002).  It 
has also been suggested that CRFR2 may have actions that oppose or modulate responses 
mediated through CRFR1 (Reyes et al., 2001; Grammatopoulos and Chrousos, 2002).   
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 CRF, the first of its peptide family to be discovered (Vale et al., 1983), has many 
behavioral and physiological effects.  In addition to increasing anxiety-like responses, 
arousal, and HPA axis activation, numerous studies demonstrate extrahypothalamic actions 
of CRF in various fear conditioning paradigms (Steckler and Holsboer, 1999; Radulovic et 
al., 1999b; Takahashi, 2001) and in learning and memory tasks such as visual discrimination, 
spatial learning, and inhibitory avoidance (Eckart et al., 1999; Landgraf, 2001; Dautzenberg 
and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002).  Urocortin is 
the second endogenous peptide in the CRF ligand family to be discovered in mammals.  It 
gets its name from the fish CRF-like peptide urotensin I (hence “uro” - 63% sequence 
similarity) and mammalian CRF (hence “cort” from corticotropin - 45% similarity) (Koob 
and Heinrichs, 1999), and it has behavioral effects similar to those of CRF (Eckart et al., 
1999).  In the brain, CRF mRNA can be found in the anterior commisure, hypothalamus 
(median eminence, Pa, and periventricular nucleus in high concentrations), the limbic system 
(including the amygdala with high concentrations in the central (Ce) and cortical nuclei, 
BST, medial and lateral septum, and low concentrations in the hippocampus), and some 
brainstem nuclei (Chappell et al., 1986; Eckart et al., 1999; Eckart et al., 2002).  UCN-
immunoreactivity can be found in the LS and hypothalamus (including low concentrations in 
the Pa and supraoptic nucleus) (Eckart et al., 1999; Eckart et al., 2002; Reul and Holsboer, 
2002).  CRF (rat/human, r/h, and ovine, o) and UCN bind with high affinity to CRFR1, and 
r/hCRF and UCN will both bind to CRFR2 with equal or less affinity than to CRFR1 
(Dautzenberg and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002; 
Reul and Holsboer, 2002).   
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A third member of the CRF ligand family, urocortin II (UCNII), shows high affinity 
for the CRFR2 receptor and little affinity for CRFR1 (Reyes et al., 2001; Dautzenberg and 
Hauger, 2002).  It is distributed primarily in subcortical areas such as the Pa, supraoptic and 
arcuate nuclei of the hypothalamus, locus coeruleus (LC), and some motor nuclei of the 
brainstem (Reyes et al., 2001; Eckart et al., 2002; Reul and Holsboer, 2002).  Administration 
of UCNII causes Fos activation in the BST, Ce, Pa, parabrachial nucleus, and nucleus of the 
solitary tract.  UCNII causes suppression of food intake (Reyes et al., 2001), and some 
studies report anxiolytic effects of UCNII administration (Valdez et al., 2002).  As is the case 
with CRFR2 receptors, the role that UCNII plays in anxiety and stress is still not completely 
understood.  Urocortin III (UCNIII), the most recently discovered mammalian ligand in the 
CRF family, is 40% homologous to UCNII and is distantly related to r/hCRF and human or 
mouse UCN.  It displays lower affinity for CRFR2 than does UCNII and has no affinity for 
CRFR1 (Lewis et al., 2001).  UCNIII mRNA expression can be found in the AH, LH, LS, 
BST, the medial amygdala, and in some brainstem nuclei (Lewis et al., 2001; Eckart et al., 
2002; Reul and Holsboer, 2002).  Because of its distribution in brain sites associated with 
stress-responding, it is likely that UCNIII is involved in controlling behavioral and endocrine 
responses to stress (Lewis et al., 2001).  Discovery of these specific ligands for CRFR1 and 
CRFR2 has provided an opportunity to pharmacologically differentiate the roles of each 
receptor subtype in various behaviors.   
Corticotropin Releasing Factor and Stress 
There are numerous examples of stress-induced changes in CRF peptide or 
immunoreactivity.  Acute stress decreases CRF in the median eminence and increases CRF in 
the LC, BST, and Pa (Chappell et al., 1986; Watts, 1996; Hatalski et al., 1998; Hsu et al., 
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1998; Helmreich et al., 1999; Jezova et al., 1999; Hsu et al., 2001).  Stress-induced changes 
in CRF occur in the Ce, as well, though the type of stressor used may affect whether CRF 
increases or decreases post-stress (Hsu et al., 1998).  An increase in Ce CRF has been seen 
following acute restraint stress or footshock (Watts, 1996; Hsu et al., 1998), but some studies 
using different types of stressors, such as osmotic stimulation or repeated restraint stress, 
have observed decreases (Watts, 1992) or no change, respectively, (Hatalski et al., 1998) in 
Ce CRF post-stress.  Stress can also affect how a CRF agonist modulates behavior.  CRF or 
UCN has activational effects on behavior such as exploration in a non-stressful environment 
(like a familiar environment) but has suppressive effects on locomotor or exploratory 
behavior in a stressful environment (like a novel environment) (Koob and Heinrichs, 1999).  
Finally, stress has been reported to affect CRFR density and binding.  Chronic social stress in 
tree shrews downregulates CRFR1 in brain regions involved in HPA axis control.  
Additionally, CRFR1 was upregulated in areas including the Cg, Ce, and La, though binding 
affinity was reduced in some of these areas (Fuchs and Flugge, 1995).   
The time course for stress-induced changes in CRF can vary depending on the 
location in the brain where the changes are occurring.  Changes can take place in minutes or 
not for hours.  For example, CRF transcription increases in the Pa within about 5 minutes 
post-stress (Kovacs and Sawchenko, 1996).  Further, changes in Pa CRF are usually only 
detectible immediately post-stress; however, changes in thalamic CRF can be seen 3 hours 
after restraint stress but not immediately afterwards (Hsu et al., 2001).  In other words, CRF 
transcription occurs quickly in brain regions involved in immediate responses to stress (like 
in the Pa to activate the HPA axis), while changes related to other functions (such as the 
modulation of learning and memory) may occur more slowly. 
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Corticotropin Releasing Factor as a Modulator of Fear and Anxiety 
 There are numerous studies demonstrating extrahypothalamic actions of CRF in 
various fear conditioning paradigms.  For example, blockade of CRFR1 in rats reduces 
conditioned freezing, blocks fear potentiated startle, and decreases conditioned ultrasonic 
vocalizations (Steckler and Holsboer, 1999; Takahashi, 2001).  It has also been demonstrated 
that three different CRF peptides (r/hCRF, oCRF, and rat UCN) dose-dependently enhance 
both tone- and context-fear conditioning in mice (Radulovic et al., 1999b).  However, there 
are exceptions to CRF’s enhancing effects on fear conditioning.  For example, unlike the 
results seen by Radulovic, et al. (Radulovic et al., 1999b) with CRF peptides, transgenic 
overproduction of CRF in mice does not affect context-dependent conditioning to a shock, 
suggesting that different types of fear conditioning may be differentially modulated by CRF 
(van Gaalen et al., 2002).   
CRF is well-documented as a modulator of anxiety.  CRFR1 antagonists reduce 
anxiety-like responses in tests such as CRF-induced startle, elevated plus maze, defensive 
withdrawal, and light-dark box exploration (Takahashi, 2001).  Additionally, urocortin 
increases anxiety-like behavior in the social interaction test, an effect that is blocked by 
administration of the CRFR1 antagonist NBI3b1996 (Gehlert et al., 2005).  Further, mice 
overproducing CRF show increased anxiety-like behavior in the light-dark box test (van 
Gaalen et al., 2002).  CRF has also been shown to increase anxiety-like responses in CRF-
potentiated startle via the BST, which, as described earlier, appears to be particularly 
associated with anxiety or unconditioned fear (Walker and Davis, 1997; Lee and Davis, 
1997; Davis, 1998).  For these reasons CRFR1 antagonists are being investigated as potential 
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drug therapies for anxiety disorders (Grammatopoulos and Chrousos, 2002; Reul and 
Holsboer, 2002).   
Syrian Hamsters and Conditioned Defeat 
As stated above, territorial aggression is a common situation in which an animal will 
encounter social conflict.  Syrian hamsters (Mesocricetus auratus) are thought to be solitary 
animals that readily defend home territories (Nowack and Paradiso, 1983).  When hamsters 
are singly housed in a laboratory, they will routinely attack intruders placed into their home 
cages (resident-intruder model), particularly if the resident is larger than its intruder.  A 
dominant-subordinate (or “winner-loser”) relationship is formed quickly (Lerwill and 
Makings, 1971), even though the severity of the encounters in terms of biting or wounding is 
usually low.  During a defeat, one hamster (usually the resident in a resident-intruder model) 
will initiate an attack, which includes pursuit of the other hamster and “biting.”  Biting is 
usually directed to the flank of the opponent, but the skin is rarely broken during this action.  
During this time the other hamster may bite back, but usually it will quickly begin to display 
defensive and submissive behaviors.  The dominant hamster may make additional attacks.  
Finally, defeat is determined when the previously attacked hamster flees or shows 
submissive/defensive behaviors without the dominant hamster making an attack.  When a 
Syrian hamster is defeated in an agonistic encounter, it will subsequently fail to display any 
territorial aggression in future social encounters, even in its home cage in the presence of a 
non-aggressive, non-threatening, smaller intruder (Potegal et al., 1993).  This change in 
social behavior is termed conditioned defeat.    
Conditioned defeat in hamsters may be a valuable model with which to study stress-
responsive behavior.  It can be reliably induced by a series of four, five-minute defeats or by 
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an acute 15-minute defeat (Huhman et al., 1991; Potegal et al., 1993; Jasnow and Huhman, 
2001).  When hamsters are defeated in this way, they subsequently show submissive 
behaviors such as flight, tail lift, tooth chatter, as well as defensive postures in the presence 
of a non-aggressive intruder (Potegal et al., 1993; Jasnow et al., 1999).  A similar change in 
behavior has been observed in defeated rats and mice (van de Poll et al., 1982; Frischknecht 
et al., 1982).  However, hamsters are a more desirable species to use because rats are social 
animals that usually show low levels of aggressive behavior unless they are housed in 
complex social situations, and aggressive strains of mice often have unacceptably high levels 
of aggression and injury.   
Defeated hamsters exhibit increased plasma adrenocorticotropic hormone (ACTH) 
and cortisol (CORT) concentrations (Huhman et al., 1990; Huhman et al., 1991; Huhman et 
al., 1992), whereas dominant hamsters do not show this response.  Additionally, CRF 
receptor (CRFR) antagonists reduce the expression of conditioned defeat as well as ACTH 
release following conditioned defeat testing (Jasnow et al., 1999).  The behavioral effect of 
acute defeat in hamsters is profound, and the physiological response consistently occurs and 
is unique to the defeated hamster.  These effects can be obtained easily with a single 
exposure to social defeat, and the response is long lasting (Huhman et al., 2003).  Further, the 
behavioral and physiological affects listed here occur in virtually all hamsters, eliminating 
the need for prescreening.  Because of the ease and consistency with which CD can be 
induced, as well as the fact that CD is a more ethologically relevant model than other 
artificial stressors (see above), conditioned defeat is a valuable model with which to study 
stress-responsive behavior.   
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Neurobiology of Conditioned Defeat 
So far little is known about the circuitry controlling conditioned defeat.  However, a 
series of studies have shown that the amygdala and the BST are both important for CD.  
Inactivation of the amygdala with the GABA agonist muscimol blocks both the acquisition 
and the expression of CD (Jasnow and Huhman, 2001), and blocking NMDA receptors in the 
amygdala with the antagonist AP5 blocks both acquisition and expression, as well (Jasnow et 
al., 2004a).  Involvement of CRF receptors has also been shown.  ICV or intra-BST injection 
of the non-selective CRFR antagonist D-Phe CRF(12-41) (D-Phe) or the CRFR2-specific 
antagonist antisauvagine-30 (ASVG) reduces the acquisition and expression of CD (Jasnow 
et al., 1999; Jasnow et al., 2004b; Cooper and Huhman, 2005a; Cooper and Huhman, 2005b).  
Additionally, a combination of unilateral Ce lesion with contralateral intra-BST injection of 
D-Phe CRF (thereby interrupting what would be ipsilateral “communication” between the Ce 
and the BST) reduces the expression of CD.  These results suggest that projections from the 
Ce to the BST are involved in the expression of CD.  It is already known that there are 
projections from the Ce to the BST that release CRF (Sakanaka et al., 1986).   Because 
CRFR antagonism in the BST reduces CD, it is likely that the projections from the Ce to the 
BST that are involved in CD are releasing CRF.   
Scope of this Dissertation  
Though there is strong evidence that the amygdala and BST are part of the 
neurocircuitry mediating CD and that extrahypothalamic CRF transmission is important in 
this circuitry, there is little else known about this system or what role CRF plays to modulate 
CD and at which receptor subtypes.  The goal of this project is to investigate the role of CRF 
type 1 and 2 receptors in CD and to identify neuroanatomical locations where CRF may be 
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acting.  Specific Aim 1 will test the hypothesis that CRF receptors modulate the expression 
of conditioned defeat by answering the following question: will a ventricular injection of 
CRF enhance the acquisition or expression of conditioned defeat after a suboptimal defeat 
encounter, and would this effect be due to cortisol release via HPA axis activity or central 
CRF transmission?  Specific Aim 2 will test the hypothesis that CRFR2, and not CRFR1, is 
important in mediating the effects of CRF on conditioned defeat by answering the following 
question: will CRFR1 or CRFR2 agonists given before testing enhance the expression of 
conditioned defeat?  Finally, Specific Aim 3 will use receptor autoradiography to test the 
hypothesis that CRFR2 receptor binding is increased following defeat by answering the 
following questions: 1) how are CRFR1 and CRFR2 distributed throughout stress circuits in 
hamster brain, particularly in the LS, amygdala, BST, and hypothalamus, and 2) are there 
differences in CRF receptor densities between defeated and non-defeated hamsters, and are 
those differences reflective of changes in CRFR1 or CRFR2 receptor densities?  
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Summary 
Social conflict is a biologically relevant stressor that can affect physiological and 
psychological markers of stress.  When a Syrian hamster loses an agonistic encounter, it 
shows elevated plasma adrenocorticotropic hormone (ACTH) and cortisol (CORT).  A 
defeated hamster also fails to display normal territorial aggression and instead displays 
submissive behavior in the presence of a non-aggressive intruder, a behavioral change termed 
conditioned defeat (CD).  Previous studies in our laboratory have shown that blockade of 
corticotropin releasing factor (CRF) receptors attenuates the expression of CD.  Because 
CRF is a critical component of the hypothalamo-pituitary-adrenal axis (HPA) response to 
stress, it is possible that the observed increases in CORT following defeat provide feedback 
important for the formation of CD.  Previous studies in our laboratory have shown that 
blocking ACTH release with a specific CRF type 1 receptor antagonist does not reduce the 
expression of CD, however, suggesting that CRF effects are central and not peripheral.  The 
purpose of the present study was to further elucidate the role of CRF in CD.  In Experiment 
1, the glucocorticoid synthesis inhibitor metyrapone was administered SC to hamsters before 
CD training or testing to determine whether CORT affects either the acquisition or 
expression of CD.  Metyrapone administration had no effect on CD, though it did 
successfully block elevations in plasma CORT following defeat.  In Experiment 2, hamsters 
received a microinjection of rat/human CRF into the lateral ventricle prior to CD training or 
testing to determine whether central CRF administration enhances CD acquisition or 
expression after a suboptimal defeat training session.  Hamsters given CRF before CD testing 
exhibited significant increases in submissive behavior compared to hamsters receiving 
vehicle.  CRF administration also increased aggressive behavior in non-defeated hamsters.  
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Collectively, these data suggest that CRF modulates CD via direct neurotropic action.  
Further, it appears that CRF has different effects on agonistic behavior depending on the 
hamster’s previous social experience. 
  
 
 
Keywords: glucocorticoids, stress, conditioned defeat, metyrapone, fear conditioning, 
aggression
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1. Introduction 
Stressful life events are linked to an increased incidence of psychopathology, 
including affective and anxiety disorders (Holsboer, 1988; Barden, 1996; Plotsky et al., 
1998; Mitchell, 1998; Arborelius et al., 1999).  In order to elucidate how stress can lead to 
psychological disorders, and to identify possible pharmacological therapies for those 
disorders, various models of stress have been developed.  Social conflict is an inevitable part 
of life in many species and thus is a more biologically relevant stressor than are other 
stressors commonly used in the laboratory, such as restraint or footshock.  When conflict 
arises, the outcome (i.e., whether the individual “wins” or “loses”) has a strong and lasting 
impact.  Losers of agonistic encounters, but not winners, exhibit increased heart rate, 
elevated blood pressure, and suppressed immune function (Bohus et al., 1993; Blanchard et 
al., 1995; Meehan et al., 1995), as well as activation of the hypothalamo-pituitary-adrenal 
(HPA) axis (Pich et al., 1993; Buwalda et al., 1999; Jasnow et al., 2001).  Defeated animals 
also exhibit many behavioral changes, such as decreased reproductive, exploratory, or 
aggressive behavior, decreased food and water intake, and increased anxiety (Heinrichs et al., 
1992; Potegal et al., 1993; Rodgers and Cole, 1993; Albonetti and Farabollini, 1994).  These 
physiological and behavioral effects can be used as targets for pharmacological or other 
manipulations to identify specific brain regions, neurochemical signals, or molecular changes 
that are important in the development of stress-induced psychological disorders. 
Syrian hamsters (Mesocricetus auratus) are thought to be solitary animals that readily 
defend their home territories (Nowack and Paradiso, 1983).  When hamsters are singly 
housed in a laboratory, they routinely attack intruders placed into their home cages (resident-
intruder model), particularly if the resident is larger than the intruder.  A dominant-
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subordinate (or “winner-loser”) relationship is formed quickly (Lerwill and Makings, 1971), 
even though the severity of the encounter between hamsters (i.e., biting or wounding) is 
usually low.  After a male hamster is defeated in an agonistic encounter, it will subsequently 
fail to display any territorial aggression in future social encounters and will instead show 
increased submissive or defensive behavior, even when these encounters occur in its own 
home cage against a smaller, non-aggressive intruder (Potegal et al., 1993).  This change in 
social behavior is termed conditioned defeat (CD).  In addition to this striking behavioral 
change, defeated hamsters exhibit increased plasma adrenocorticotropic hormone (ACTH) 
and cortisol (CORT) concentrations following a social encounter (Huhman et al., 1990; 
Huhman et al., 1991; Huhman et al., 1992), whereas dominant hamsters do not.   
Corticotropin releasing factor (CRF) is a 41-amino acid peptide (Vale et al., 1983) 
located in the anterior pituitary and throughout the brain (Chappell et al., 1986; Eckart et al., 
1999; Eckart et al., 2002).  It has many behavioral and physiological effects, including 
increased anxiety-like responding, increased arousal and HPA axis activation, and 
enhancement of learning and memory in tasks such as visual discrimination, spatial learning, 
inhibitory avoidance, and fear conditioning (Eckart et al., 1999; Landgraf, 2001; 
Dautzenberg and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002).  
CRF is a critical component of the endocrine response to stress.  Following exposure to a 
stressful event, CRF is released from the parvicellular portion of the paraventricular nucleus 
(Pa) and it triggers release of ACTH from anterior pituitary corticotrophes.  ACTH, in turn, 
stimulates adrenocortical release of glucocorticoids, which has a number of effects including 
gluconeogenesis to provide energy (to sustain the “flight or flight” response) and reduced 
inflammation.  Glucocorticoids also provide feedback to the brain to control the HPA axis 
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response to stress.  In addition to the critical role of CRF in the HPA axis response to stress, 
CRF peptides and receptors are distributed throughout the brain (Bittencourt and Sawchenko, 
2000; Lewis et al., 2001; Reyes et al., 2001; Dautzenberg and Hauger, 2002; Eckart et al., 
2002; Reul and Holsboer, 2002), suggesting a wider role for this peptide.  Consistent with 
this view, numerous studies demonstrate extrahypothalamic actions of CRF in various fear 
conditioning paradigms (Steckler and Holsboer, 1999; Radulovic et al., 1999b; Takahashi, 
2001).   
CRF may modulate agonistic behavior by its regulation of glucocorticoids.  Acute 
increases in glucocorticoids have been shown to increase aggression or submission 
depending on the social context (Leshner, 1980; Leshner, 1983).  Glucocorticoids might 
produce these variable effects by acting on brain mechanisms to increase general arousal and 
thereby increase the salience of incoming stimuli.  More recently, glucocorticoids have been 
proposed to directly modulate ongoing aggressive behavior through rapid effects on 
neurotransmitter systems (Haller et al., 1998; Mikics et al., 2004).  Glucocorticoids might 
also affect future agonistic behavior by modulating memory of the social interaction.  
Increased glucocorticoids produced by an acute stressful experience have been shown to 
facilitate the acquisition of some associative memory tasks (Beylin and Shors, 2003).  
Likewise, administration of corticosterone and glucocorticoid receptor agonists have been 
shown to enhance the consolidation of memories for emotionally arousing experiences 
(Buchanan and Lovallo, 2001; Roozendaal et al., 2001; Hui et al., 2004).  Also, the 
suppression of glucocorticoid synthesis with metyrapone impairs memory consolidation on 
emotionally motivated tasks such as a water maze and inhibitory avoidance (Roozendaal et 
al., 1996; Liu et al., 1999).  The basolateral amygdala (BLA) is the primary brain region that 
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mediates the effects of stress and glucocorticoids on memory consolidation and retrieval 
(Roozendaal and McGaugh, 1997; Roozendaal et al., 2001; Roozendaal et al., 2002; 
Roozendaal et al., 2004).   
 Previous work in our laboratory suggests that CD is modulated by CRF.  D-Phe 
CRF(12-41), a non-selective CRF receptor antagonist, reduces CD, whereas CP-154,526, a 
selective CRF 1 receptor antagonist, blocks the plasma ACTH response to defeat but does 
not reduce the display of submissive behavior (Jasnow et al., 1999).  This result suggests that 
CRF is acting via a central and not a peripheral mechanism.  On the other hand, these data 
suggest that adrenocorticoids can have a pronounced effect on behavior, including agonistic 
behavior.  One goal of the present study was to determine whether CRF modulates CD by 
acting centrally, peripherally, or both.  Based on the growing literature showing effects of 
glucocorticoids on agonistic behavior, as well as learning and memory, it remains plausible 
that administration of the glucocorticoid synthesis inhibitor metyrapone might reduce the 
acquisition or expression of CD.  In addition, we hypothesized that intracerebroventricular 
injection of CRF would enhance the acquisition as well as the expression of CD following a 
suboptimal defeat. 
2. Materials and Methods 
Subjects 
Male Syrian hamsters were purchased from Charles River Laboratories.  
Experimental animals were three to four months old and weighed 120-140 g at the start of the 
study.  The animals were individually housed for 10 days to two weeks prior to testing in a 
temperature controlled (20ºC ± 2º) colony room and were maintained on a 14:10h light:dark 
cycle.  Older animals that weighed 160-180g were housed individually and used as resident 
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aggressors during the defeat phase of the CD protocol.  Younger animals (two months) that 
weighed 100-110g were group-housed (five animals per cage) and were used as non-
aggressive intruders during the testing phase.  All animals were housed in polycarbonate 
cages (20 x 40 x 20 cm) with corncob and cotton bedding materials and wire mesh tops.  
Food and water were available ad libitum.  The cages of experimental animals and resident 
aggressors were not changed for at least one week prior to testing.  All training or testing 
occurred within the first three hours after the onset of the dark phase of the light:dark cycle in 
order to minimize circadian variation of the dependent measures.  All experimental animals 
were handled daily for at least one week prior to the beginning of any experiment in order to 
habituate them to the stress of being handled by the experimenter.  During the experiment if 
any animal was bitten such that it bled, the encounter was stopped and the animal was 
examined and treated immediately.  All procedures and protocols were approved by the 
Georgia State University Institutional Animal Care and Use Committee.   
Experiment 1a 
To test metyrapone’s effectiveness at blocking increased CORT release following 
defeat, 18 animals were injected (SC) with metyrapone (50 mg/kg or 100 mg/kg in 0.2 ml 
vehicle) or vehicle 90 min prior to a 15-min training session with a resident aggressor.  
Metyrapone [2-methyl-1,2-di-3pyridyl-1-propanone (Sigma)] was dissolved in polyethylene 
glycol and diluted with saline to reach a final concentration of 40% polyethylene glycol.  
Drug doses and delay between injection and testing were selected based on previous research 
(Roozendaal et al., 1996; Liu et al., 1999).  Immediately following social defeat, hamsters 
were rapidly decapitated and trunk blood was collected for CORT radioimmunoassay (RIA).  
Trunk blood was transferred to heparinized tubes kept on ice, centrifuged at 4ºC and 3500 
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rpm for 20 min, and the plasma was stored at -20ºC until assay.  Total plasma cortisol was 
measured in duplicate samples at the Endocrine Core Laboratory, Yerkes Primate Research 
Center of Emory University, using an RIA kit produced by Diagnostic Systems Laboratories 
(Webster, TX).  The normal range for this assay is 0.5 – 60 µg/dl in a 25µl dose.  Intraassay 
variation was 4.9%, and all samples were run together. 
Experiment 1b 
Experiment 1b was designed to test the effect of metyrapone on the acquisition and 
expression of CD.  To investigate effects on acquisition, 20 adult male Syrian hamsters were 
given metyrapone (50 mg/kg) or vehicle 90 min prior to a 15-min CD training session with a 
resident aggressor.  To investigate effects on expression, 18 adult male hamsters were given 
metyrapone (50 mg/kg) or vehicle 90 min prior to a 5-min CD test.   
The conditioned defeat model has been described elsewhere (Jasnow and Huhman, 
2001) and is briefly described here.  Prior to each experiment, the animals were matched by 
weight and randomly assigned to groups.  On the training day, experimental animals were 
transported to a testing room.  Training consisted of one 15-min exposure to a resident 
aggressor in the aggressor’s home cage.  The resident aggressor reliably attacked the 
experimental animal, and all of the experimental animals displayed high levels of submissive 
and defensive behavior during training.  To correct for the total duration of defeat, exposure 
time began following the first attack by the resident aggressor (which usually occurred within 
the first 30 sec of the training trial).  Twenty-four hours following defeat, experimental 
animals were tested for CD.  The animals were transported to the testing room and a non-
aggressive intruder was placed in their home cage for 5 min.  Total durations of submissive, 
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aggressive, social, and non-social behaviors were recorded during testing sessions (see 
Behavioral Scoring and Analysis).   
Experiment 2  
Experiment 2 was designed to test the hypothesis that ICV injection of CRF would 
enhance the acquisition and expression of CD following a suboptimal defeat training session.  
A single 5-min defeat session has been shown previously to elicit very low levels of 
submissive behavior in male Syrian hamsters when they are tested 24h later (Jasnow et al., 
2002).  Therefore, a 5-min defeat session is considered suboptimal for inducing CD and 
provides the opportunity to observe a pharmacological enhancement of CD.  Hamsters were 
deeply anesthetized with sodium pentobarbital (90 mg/kg) and placed in a stereotaxic 
instrument.  The skull was leveled between lambda and bregma prior to implantation of a 
guide cannula.  Hamsters were then implanted unilaterally with a 4 mm, 26-gauge guide 
cannula aimed at the lateral ventricle (LV).  Final stereotaxic coordinates were 0.8 mm 
anterior and 1.1 mm lateral to bregma.  The injection cannula (33-gauge) extended 1.1 mm 
beyond the guide to reach the final depth of -3.4 mm below dura.  Dummy stylets were 
placed in the guide cannulae in order to keep them unobstructed.  Hamsters were allowed at 
least one week of recovery before commencing behavioral experiments.   
To test for effects on acquisition, hamsters received injection of either vehicle or 
rat/human CRF (r/hCRF; 0.2 nmol) 40 mins prior to a 5-min defeat training session as briefly 
described above and elsewhere (Jasnow and Huhman, 2001).  To test for effects on 
expression of CD, a different group of hamsters received either vehicle or r/hCRF (0.2 nmol) 
40 mins prior to testing for CD (24h following defeat training).  Testing for CD occurred as 
described in Experiment 1.  Because r/hCRF has been reported to have anxiogenic effects 
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(Takahashi et al., 1989; Owens and Nemeroff, 1993; Weiss et al., 1994; Heinrichs et al., 
1997; Holsboer, 1999; Steckler and Holsboer, 1999; Arborelius et al., 1999; Eckart et al., 
1999; Radulovic et al., 1999a; Takahashi, 2001), a no-defeat control group was included in 
Experiment 2 to control for a main effect of r/hCRF on behavior.  One third of the hamsters 
were exposed to a resident aggressor’s empty cage for 5 min in lieu of being defeated, and 
drug was administered as described above.  At the conclusion of testing, hamsters were 
sacrificed and the brains collected for verification of the injection site.   
 CRF (rat/human CRF; Sigma) was solubilized in sterile saline (0.9%).  Hamsters 
received either 0.0 or 0.2 nmol r/hCRF into the LV.  This dose was determined from a dose-
response curve obtained in our laboratory using either 0.0, 0.2 or 2.0 nmol r/hCRF (Faruzzi 
and Huhman, 2001).  Microinjections were made with a 5.0 µl Hamilton syringe connected to 
the injection cannula via polyethylene tubing.  A final volume of 3.0 µl was injected over the 
course of 1 min, and the injection cannula was left in place for an additional 1 min to allow 
for drug diffusion.  Hamsters were allowed to move freely during injections. 
Following testing, each hamster was given a lethal dose of sodium pentobarbital.  A 
volume of 0.5 µl of ink was microinjected using the same length injection needle as was used 
to administer r/hCRF, and the brains were removed and stored in 10% formalin for at least 
24h.  A razor blade was used to slice through the LV.  A hit was determined by the presence 
of ink in the LV and a miss was assigned if the ink was primarily located above the lateral 
ventricles or in another location.  Any animal that was assigned a miss was not used in 
statistical analysis.   
 
 
  
26
Behavioral Scoring and Analysis 
All testing sessions were recorded and later scored by an observer blind to the 
experimental conditions using Noldus Observer v. 5.0 (Noldus Information Technology, 
Wageningen, Netherlands).  Total duration of four classes of behavior were scored during 
each 5 min test: 1) Submissive: flee, avoid, tail up, upright and side defense, full submissive 
posture, stretch-attend, head flag, attempted escape from the cage; 2) Aggressive: upright and 
side offense, chase, and attack (including bite); 3) Social: attend, approach, investigate, sniff, 
nose touching, and flank marking; 4) Nonsocial: locomotion/exploration, self-groom, 
nesting, feeding, and sleeping.  A subset of sessions was scored by a second observer, and 
inter-observer reliability on the total duration of submissive behavior was >90%.  When drug 
was administered prior to social defeat, training sessions were recorded as well and scored 
for the total duration of agonistic behavior.   
The total durations of submissive, aggressive, social, and non-social behavior were 
individually analyzed using T-tests or one-way between-subjects analyses of variance 
(ANOVAs) with drug treatment as the between-subjects factor.  Tukey and Least Significant 
Difference (LSD) post hoc tests were used for pairwise comparisons.  Nonparametric 
statistics (Mann-Whitney U tests) were used for any comparisons with a significant Levene’s 
test of homogeneity of variances.  Planned comparisons were used to analyze Experiment 2 
data.  Alpha was set at p<0.05. 
3. Results 
Experiment 1  
Metyrapone effectively blocked the increase in cortisol generally observed after 
social defeat (F(2,15)=40.5, p<0.001, Tukey tests p<0.001; Figure 1).  In subsequent 
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experiments, we used the lowest effective dose only (50 mg/kg).  When given prior to social 
defeat, however, this dose of metyrapone did not significantly alter submissive behavior 
during testing (t(17)=0.03, p>0.05; Figure 2a).  In addition, metyrapone given before training 
did not significantly alter aggressive, social, or nonsocial behavior during testing (T-tests, 
p>0.05).  One animal was excluded from the study because it was not defeated by the 
resident aggressor.  Also, when metyrapone was given prior to testing, it did not significantly 
alter the expression of submissive behavior (t(16)=0.97, p>0.05; Figure 2b) or aggressive, 
social, or nonsocial behaviors (T-tests, p>0.05). 
Experiment 2  
Analysis using planned comparisons (defeat-CRF vs. defeat-vehicle and no-defeat-
CRF vs. defeat-CRF) revealed that ICV r/hCRF significantly enhanced the expression of CD 
(Figure 3).  Defeated hamsters that received r/hCRF prior to testing displayed significantly 
more submissive behavior when tested with a non-aggressive intruder than did non-defeated 
hamsters receiving r/hCRF or defeated hamsters receiving vehicle, F(1,9)=13.29 and 
F(1,8)=19.79, respectively, p<0.05.  Defeated hamsters that received r/hCRF also showed 
significantly less nonsocial behavior during testing than did defeated hamsters that received 
vehicle (F(1,8)=6.11, p<0.05).  However, further analysis revealed no differences in the types 
of nonsocial behaviors displayed by defeated hamsters receiving r/hCRF compared to 
defeated controls.  These hamsters displayed normal exploratory behavior for the majority of 
the 5-min test.  Finally, non-defeated hamsters receiving r/hCRF prior to testing displayed 
significantly more aggressive behavior than did defeated hamsters receiving r/hCRF (Mann-
Whitney U test, Z=-2.30, p<0.05).  There was no effect of r/hCRF on the acquisition of CD 
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(F(1,20)=0.06 and F(1,24)=0.16, p>0.05) or on aggressive behavior (Mann-Whitney U test, 
Z=-0.84 and F(1,24)=0.14, p>0.05). 
4. Discussion 
 Collectively, the data presented here indicate that CRF modulates the expression, but 
not the acquisition of CD, and that this effect is not mediated by the HPA axis.  In the current 
study, administration of r/hCRF altered the expression of CD while blockade of 
glucocorticoid synthesis with metyrapone did not.  This finding is consistent with previous 
data from our laboratory showing that blockade of CRF type 1 receptors significantly 
attenuates the HPA axis response in defeated hamsters but does not affect CD (Jasnow et al., 
1999).  Therefore, it would appear that CRF modulates CD through central circuitry and does 
not affect CD via the peripheral hormonal stress response. 
 We also observed a significant increase in aggressive behavior in non-defeated 
hamsters that received r/hCRF prior to testing, suggesting that CRF’s activational effects on 
agonistic behavior are dependent on the previous social experience of the hamster.  Thus, 
defeated hamsters receiving r/hCRF show increases in submissive behavior while non-
defeated hamsters exhibit increases in aggressive behavior.  There are two important 
implications of these data.  First, CRF appears to affect agonistic behavior broadly and not 
merely defensive or fearful responses as was suggested from previous studies examining CD 
(Jasnow et al., 1999).  Second, these data strongly suggest that there are separate neural 
mechanisms controlling opposing aspects of agonistic behavior.  If all dominant and 
subordinate behavior was controlled by the same neural circuit, then it would be expected 
that manipulations that decrease one behavior would necessarily increase the opposing 
behavior.  However, these and previous data (Jasnow et al., 1999; Jasnow and Huhman, 
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2001; Jasnow et al., 2004a) demonstrate that, although increases in submissive behavior are 
accompanied with decreases in aggressive behavior, a decrease in or the absence of 
submissive behavior is not necessarily accompanied by a return of territorial aggression.  
Pharmacological manipulations that decrease submission are instead associated with 
increased social or nonsocial behavior, collectively suggesting that subtypes of agonistic 
behavior are controlled by separate neural mechanisms.  The fact that CRF may increase 
either submissive or aggressive behavior suggests that it can have activational effects on 
either aspect of agonistic behavior, but other factors (previous social experience, for 
example) determine which behavior will be expressed.  Ongoing experiments in our 
laboratory are using additional control groups to investigate whether CRF is indeed 
increasing multiple aspects of agonistic behavior and not just submissive behavior.  
Additionally, we are examining whether these effects are specific to agonistic behavior or 
result from a state of generalized anxiety or increased locomotor behavior. 
In many animals, social defeat results in increased levels of plasma glucocorticoids 
and decreased aggressive behavior (Brain, 1980; Sapolsky, 1990; Schuett et al., 1996).  In 
the present study, we showed that blocking glucocorticoid synthesis did not alter the 
acquisition or expression of CD.  This result is consistent with previous research from our 
laboratory showing that blockade of plasma ACTH release fails to reduce CD (Jasnow et al., 
1999).  Our results are also similar to those found for green anole lizards in which blocking 
CORT synthesis during exposure to an aggressive video did not alter future aggressive 
behavior to a novel challenger (Yang and Wilczynski, 2003).  However, our results contrast 
with recent evidence showing that glucocorticoids facilitate the acquisition of stress-induced 
changes in behavior (Calvo et al., 1998; Liu et al., 1999; Cordero et al., 2002).  Recent 
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evidence also suggests that the elevation of glucocorticoids that occurs following social 
defeat modulates the development of aggression in Syrian hamsters (Wommack et al., 2003).  
Our study suggests that the role for glucocorticoids in regulating behavioral responses to 
social defeat during puberty may not extend into adulthood.  In sum, although an acute social 
defeat produces activation of the HPA axis, it appears that glucocorticoid feedback is not a 
critical part of the neural circuitry regulating CD. 
CRF has previously been shown to modulate social learning in rats (Heinrichs, 2003).  
In this earlier study, the CRF antagonist D-Phe CRF impaired social learning and r/hCRF 
enhanced social learning when given prior to an initial social exposure.  However, in the 
present study, the fact that there is an effect on expression only and not on the acquisition of 
conditioned defeat suggests that CRF may not have a role in the learning of CD.  It is 
possible that CRF is involved in the retrieval of social memories, though it is also possible 
that CRF only has general motivational effects on agonistic behavior.  Our lab does have 
preliminary data suggesting that CRF antagonists block the acquisition of CD, indicating that 
CRF may have a role in learning.  More research is necessary to better understand the role 
CRF is playing in modulating agonistic behavior and conditioned defeat in hamsters. 
 In conclusion, the present study demonstrates that CRF has a direct neurotrophic 
effect on stress-responsive behavior in Syrian hamsters.  Blockade of glucocorticoid 
synthesis with metyrapone blocks neither the acquisition nor expression of submissive 
behavior in previously defeated hamsters.  On the other hand, blockade of CRF receptors 
reduces the expression submissive behavior (Jasnow et al., 1999) and central administration 
of CRF enhances the expression of submissive behavior.  The current study also 
demonstrates that CRF has a potent activational effect on agonistic behavior, but the type of 
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behavior that is affected depends on the animal’s previous social experience.  Further studies 
will elucidate the role of CRF receptors in conditioned defeat by examining which receptor 
subtype(s) is responsible for modulating submissive and aggressive behavior.  It will also be 
important to determine where in the brain CRF is acting to modulate each aspect of agonistic 
behavior.  
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Figure 2.1.  Means ± SEM of cortisol in male hamsters receiving metyrapone (0.0, 50.0, 100 
mg/kg SC).  These data indicate that metyrapone significantly attenuated the cortisol 
response to a 15-min social defeat stressor.  (p<0.05) 
 
Figure 2.2.  Means ± SEM of duration of submissive, aggressive, social and nonsocial 
behavior in male hamsters receiving metyrapone either a) before training (acquisition effects) 
or b) before CD testing (expression effects).  (p>0.05) 
 
Figure 2.3.  Means ± SEM of duration of submissive, aggressive, social and nonsocial 
behavior in defeated and non-defeated male hamsters receiving r/hCRF either a) before 
training (acquisition effects) or b) before CD testing (expression effects).  (planned 
comparisons: defeat-CRF vs. defeat-vehicle and no-defeat CRF vs. defeat-CRF; *p<0.05) 
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ABSTRACT 
The non-specific corticotropin releasing factor receptor (CRFR) agonist rat/human 
CRF has previously been shown to enhance the expression of conditioned defeat (CD) in 
male Syrian hamsters.  In addition, it has been shown that this agonist may increase the 
expression of aggressive behavior in previously undefeated hamsters, suggesting a general 
role for CRF in the expression of agonistic behavior.  The current study further investigated 
the effects of CRF on agonistic behavior by examining which CRFR subtype is mediating 
these effects.  In Experiment 1a, previously defeated and non-defeated hamsters received 
vehicle, ovine CRF (oCRF), a CRFR1-specific agonist, or human urocortin II (UCNII), a 
CRFR2-specific agonist, prior to testing with a non-aggressive intruder.  oCRF significantly 
enhanced the expression of CD in defeated hamsters and showed a trend toward increased 
aggressive behavior in non-defeated hamsters, while UCNII had no effect.  In Experiment 1b, 
previously defeated and non-defeated hamsters received vehicle or antisauvagine-30 
(ASVG), a CRFR2-specific antagonist, in addition to receiving vehicle or oCRF prior to 
testing.  Administration of ASVG did not block the replication of previously observed effects 
of oCRF on aggressive or submissive behavior, suggesting that oCRF is not working via 
spillover to CRFR2.  Finally, Experiment 2 was designed to test whether the effects of oCRF 
observed in Experiment 1 were due to increases in anxiety-like behavior.  The results showed 
no effect of ICV oCRF injection on open field or defensive withdrawal behavior in compared 
to vehicle hamsters.  Overall, these results suggest that activation of CRFR1 has potent 
enhancing effects on the expression of agonistic behavior in Syrian hamsters.  Further, this 
effect appears to be modulated by the hamster’s previous social experience. 
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INTRODUCTION 
 When a male Syrian hamster (Mesocricetus auratus) is defeated in an agonistic 
encounter, it will subsequently fail to display any territorial aggression in future social 
encounters.  The hamster will instead show increased submissive or defensive behavior, even 
when these encounters occur in its own home cage against a smaller, non-aggressive intruder 
(Potegal et al., 1993).  This change in behavior is termed conditioned defeat (CD).  In 
addition to this striking behavioral change, defeated hamsters exhibit increased plasma 
adrenocorticotropic hormone (ACTH) and cortisol (CORT) concentrations following a social 
encounter (Huhman et al., 1990; Huhman et al., 1991; Huhman et al., 1992), whereas 
dominant hamsters do not.  These behavioral and physiological changes have led to an 
investigation of CD as both a model of stress and of fear conditioning.  These investigations 
have suggested, among other things, a role for corticotropin releasing factor (CRF) in the 
expression and possibly the acquisition of CD.   
CRF is a 41-amino acid peptide (Vale et al., 1983) located in the anterior pituitary 
and throughout the brain (Chappell et al., 1986; Eckart et al., 1999; Eckart et al., 2002).  It 
has many behavioral and physiological effects, including increased anxiety-like responding, 
increased arousal and activation of the hypothalamo-pituitary-adrenal (HPA) axis.  CRF is a 
critical component of the HPA axis response to stress, a response which has a number of 
effects including gluconeogenesis (to sustain the “flight or flight” response), reduced 
inflammation, as well as negative feedback to the brain to ultimately turn off the stress 
response.  In addition to the critical role of CRF in the HPA axis response to stress, CRF 
peptides and receptors are distributed throughout the brain (Bittencourt and Sawchenko, 
2000; Lewis et al., 2001; Reyes et al., 2001; Dautzenberg and Hauger, 2002; Eckart et al., 
  
40
2002; Reul and Holsboer, 2002), suggesting a wider role for this peptide.  Consistent with 
this view, numerous studies demonstrate extrahypothalamic actions of CRF in various fear 
conditioning paradigms (Steckler and Holsboer, 1999; Radulovic et al., 1999b; Takahashi, 
2001) and in learning and memory tasks such as visual discrimination, spatial learning, and 
inhibitory avoidance (Eckart et al., 1999; Landgraf, 2001; Dautzenberg and Hauger, 2002; 
Eckart et al., 2002; Grammatopoulos and Chrousos, 2002).   
Previous research in our laboratory (Jasnow et al., 1999; Jasnow et al., 2004b; 
Cooper and Huhman, 2005a) has indicated that nonselective CRF receptor (CRFR) 
antagonists can attenuate the expression of conditioned defeat.  We have also shown that ICV 
administration of the nonselective receptor agonist rat/human CRF enhances CD in 
previously defeated hamsters while it enhances territorial aggression in hamsters that have 
not previously been defeated (A.N. Faruzzi, M.A. Cooper, and K.L. Huhman, submitted).  In 
addition to the nonspecific CRF receptor antagonist D-Phe CRF (12-41), we have also shown 
that administration of  the CRFR2-specific antagonist antisauvagine-30 attenuates the 
expression of CD (Jasnow et al., 1999; Jasnow et al., 2004b; Cooper and Huhman, 2005a), 
while the CRFR1 specific antagonist CP-154,526 does not (Jasnow et al., 1999; Cooper and 
Huhman, 2005a).  Although these results suggest that CRFR2, and not CRFR1, is modulating 
CD, investigations by other laboratories into the role of CRF in agonistic behavior have 
indicated a role for CRFR1.  For example, the CRFR1 receptor antagonist antalarmin reduces 
defensive behavior in defeated mice (Robison et al., 2004) and reduces anxious and fearful 
responses normally displayed when rhesus macaques are visually exposed to conspecifics 
(Habib et al., 2000).  Additionally, administration of the CRFR1 antagonist SSR125543A 
reduces territorial aggression in male Syrian hamsters (Farrokhi et al., 2004).  There is also 
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evidence that decreased CRFR2 binding reduces maternal aggression but does not affect 
intermale aggression in CRFR2-mutant mice (Gammie et al., 2005), suggesting that CRFR2 
does not play an important role in offensive aggression.  Thus, while data from our lab have 
initially supported a more important role for the CRFR2 in the modulation of CD, other 
published data indicate that the CRFR1 may also have important effects on agonistic 
behavior.  The purpose of the present study was to use specific CRF receptor agonists to 
investigate which CRF receptor mediates the reported effects of CRF on agonistic behavior 
in Syrian hamsters.   
 The standard training protocol for CD involves a 15-min defeat training session.  A 
single 5-min defeat session elicits only very low levels of submissive behavior in male Syrian 
hamsters when they are tested 24h later (Jasnow et al., 2002).  Because a 5-min defeat 
session produces only a low level of CD, it provides the opportunity to observe a 
pharmacological enhancement of CD.  Using this abbreviated defeat training, we have 
previously shown that ICV injection of r/hCRF enhances the expression of submissive 
behavior in hamsters (A.N. Faruzzi, M.A. Cooper, and K.L. Huhman, submitted).  The 
current study used this design to test whether administration of ovine CRF (oCRF), a CRFR1 
specific agonist (Dautzenberg and Hauger, 2002), or urocortin II (UCNII), a CRFR2 specific 
agonist (Reyes et al., 2001; Jahn et al., 2004), would enhance the expression of conditioned 
defeat.  This study also tested whether oCRF or UCNII would enhance the expression of 
aggressive behavior in hamsters that had not previously experienced social defeat.  Finally, 
because CRFR1 binding is associated with increases in anxiety-like behavior (Heinrichs et 
al., 1997; Smith et al., 1998; Liebsch et al., 1999; Radulovic et al., 1999b; Takahashi, 2001; 
Zorrilla et al., 2002; van Gaalen et al., 2002; Spina et al., 2002; Gutman et al., 2003; 
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Seymour et al., 2003), which may lead to increases in defensive behavior and flight, we 
examined also whether administration of oCRF increases anxiety-like behavior by testing 
hamsters in open field (Wilson et al., 1976; Crawley, 1985; Lister, 1990; Chaouloff et al., 
1994) and defensive withdrawal tests (Welker, 1959; Blanchard et al., 1974; Takahashi et al., 
1989). 
METHODS 
Experiment 1 
Subjects 
Male Syrian hamsters were purchased from Charles River Laboratories.  
Experimental animals were three to four months old and weighed 120-140 g at the start of the 
study.  These animals were individually housed for 10 days to two weeks prior to testing in a 
temperature controlled (20ºC ± 2º) colony room and were maintained on a 14:10h light:dark 
cycle.  Older animals that weighed 160-180g were housed individually and used as resident 
aggressors during the defeat phase of the CD protocol.  Younger animals (two months) that 
weighed 100-110g were group-housed (five animals per cage) and were used as non-
aggressive intruders during the testing phase.  All animals were housed in polycarbonate 
cages (20 x 40 x 20 cm) with corncob and cotton bedding materials and wire mesh tops.  
Food and water were available ad libitum.  The cages of experimental animals and resident 
aggressors were not changed for at least one week prior to testing to allow the animals to 
scent mark their territory.  All training or testing occurred within the first three hours after 
the onset of the dark phase of the light:dark cycle in order to minimize circadian variation of 
the dependent measures.  All experimental animals were handled daily for one week prior to 
training in order to habituate them to the stress of being handled by the experimenter.  
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Different groups of hamsters were used for each experiment.  During the experiment if any 
animal was bitten such that it bled, the encounter was stopped and the animal was examined 
and treated immediately.  All procedures and protocols were approved by the Georgia State 
University Institutional Animal Care and Use Committee.   
Surgeries 
Adult male Syrian hamsters were unilaterally implanted with guide cannulae aimed at 
the lateral ventricle (LV).  Hamsters were deeply anesthetized with sodium pentobarbital 
(90 mg/kg) and were placed in a stereotaxic instrument.  The skull was leveled between 
lambda and bregma prior to implantation of the guide cannula.  Hamsters were then 
implanted unilaterally with a 4 mm, 26-gauge guide cannula aimed at the lateral ventricle.  
Final stereotaxic coordinates were 0.8 mm anterior and 1.1 mm lateral to bregma.  The 
injection cannula (33-gauge) extended 1.1 mm beyond the guide to reach the final depth of -
3.4 mm below dura.  Dummy stylets were placed in the guide cannulae in order to keep them 
unobstructed.  Hamsters were allowed at least one week of recovery before commencing 
behavioral experiments.   
Experiment 1a Procedures 
Experiment 1a was designed to test the hypothesis that ICV injection of ovine CRF 
(oCRF), a CRFR1-specific agonist, or urocortin II (UCNII), a CRFR2-specific agonist, 
enhances the expression of submissive behavior in previously defeated hamsters.  Hamsters 
received either vehicle, UCNII or oCRF 30 mins prior to CD testing.  The conditioned defeat 
model has been described elsewhere (Jasnow and Huhman, 2001) and is briefly described 
here.  Prior to each experiment, the animals were matched by weight and randomly assigned 
to groups.  On the training day, experimental animals were transported to a testing room.  
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One half of the animals underwent CD training.  This training typically consists of one 15-
min exposure to a resident aggressor in the aggressor’s home cage.  In the current 
experiments, however, training occurred for only 5 min in order to produce a suboptimal 
defeat.  During each 5-min training session, the resident aggressor reliably attacked the 
experimental animal, and all of the experimental animals displayed high levels of submissive 
and defensive behavior during training.  To correct for the total duration of defeat, exposure 
time began following the first attack by the resident aggressor (which usually occurred within 
the first 30 sec of the training trial).  Because we have previously observed an effect of CRF 
on aggressive behavior in non-defeated hamsters (Faruzzi, Cooper, and Huhman, submitted), 
a no-defeat-vehicle group was also included for comparison.  In this group, the other half of 
the experimental hamsters was exposed to a resident aggressor’s empty cage for 5 min in lieu 
of being defeated, and drug was administered as described above.  Twenty-four hours 
following defeat or novel cage exposure, experimental animals were tested for CD.  The 
animals were transported to the testing room and a non-aggressive intruder was placed in 
their home cage for 5 min.  Total durations of submissive, aggressive, social, and non-social 
behaviors were recorded during testing sessions (see Behavioral Scoring and Analysis).  At 
the conclusion of testing, all hamsters were sacrificed and the brains were collected for 
verification of the injection site as described below.   
Experiment 1b Procedures 
Experiment 1b was designed to determine whether effects of oCRF on agonistic 
behavior observed in Experiment 1a could be due to “spillover” binding at CRFR2.  
Treatment occurred as described in Experiment 1a, with the exception that hamsters received 
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vehicle or the CRFR2-specific antagonist ASVG in addition to oCRF.  Training and testing 
for CD occurred as described in Experiment 1a.   
Drug Preparation and Injections  
 UCNII (human urocortin II; Phoenix Pharmaceuticals, Belmont CA) was solubilized 
in 25% DMSO in sterile saline (0.9%).  Hamsters received 0, 0.2 or 1.0 nmol UCNII (Valdez 
et al., 2002).  oCRF (ovine corticotropin releasing factor; Phoenix Pharmaceuticals) was 
solubilized in 25% DMSO in sterile saline (0.9%).  Hamsters received 0, 0.10 or 1.0 nmol 
oCRF (Imaki et al., 1996; Buwalda et al., 1998; Valdez et al., 2002) into the LV.  ASVG 
(antisauvagine 30; Polypeptide Laboratories, Torrence CA) was solubilized in deionized 
water.  Hamsters received 0 or 2.74 nmol ASVG into the LV (Takahashi et al., 2001).   
Microinjections were made with a 5.0 µl Hamilton syringe connected to the injection 
cannula via polyethylene tubing.  In Experiment 1a, oCRF/UCNII/vehicle was given 30 mins 
prior to CD testing.  In Experiment 1b, half the hamsters received ASVG/vehicle 10 mins 
prior to receiving oCRF/vehicle; the other half of the animals received ASVG/vehicle with 
oCRF/vehicle as a cocktail 30 mins prior to testing (drug solubilization was adjusted to 
maintain desired concentrations for either individual injections or cocktail injections).  A 
final volume of 3.0 µl was injected over the course of 1 min for any individual injection, and 
the injection cannula was left in place for an additional 1 min to allow for drug diffusion.  
Hamsters were allowed to move freely during injections. 
Following testing, each hamster was given a lethal dose of sodium pentobarbital.  A 
volume of 0.5 µl of ink was microinjected over 30 sec using the same length injection needle 
as was used to administer agonists, and the brains were removed and stored in 10% formalin 
for at least 24h.  A razor blade was used to slice through the LV.  A hit was determined by 
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the presence of ink in the LV and a miss was assigned if the ink was primarily located above 
the lateral ventricles or in another location.  Any animal that was assigned a miss was not 
used in the statistical analysis.   
Behavioral Scoring and Analysis 
All testing sessions were recorded and later scored by an observer blind to the 
experimental conditions using Noldus Observer v. 5.0 (Noldus Information Technology, 
Wageningen, Netherlands).  During each 5 min test, the total duration (sec) of four classes of 
behavior were scored and grouped as follows: 1) Submissive: flee, avoid, tail up, upright and 
side defense, full submissive posture, stretch-attend, head flag, attempted escape from the 
cage; 2) Aggressive: upright and side offense, chase, and attack (including bite); 3) Social: 
attend, approach, investigate, sniff, nose touching, and flank marking; 4) Nonsocial: 
locomotion/exploration, self-groom, nesting, feeding, and sleeping.  A subset of sessions was 
scored by a second observer, and inter-observer reliability on the total duration of submissive 
behavior was >90%.   
The total durations of submissive, aggressive, social, and non-social behavior were 
individually analyzed with planned comparisons using T-tests or multivariate analysis of 
variance with drug and social experience as the between-subjects factors.  Least Significant 
Difference (LSD) post hoc tests were used for pairwise comparisons.  Nonparametric 
statistics (Mann-Whitney U tests or Kruskall-Wallis tests) were used for any comparisons 
with a significant Levene’s test of homogeneity of variances.  Alpha was ascribed at p<0.05. 
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Experiment 2    
The purpose of Experiment 2 was to determine whether the effects of oCRF on 
submissive or aggressive behavior are associated with increases in general anxiety-like 
behavior.   
Subjects 
Experimental hamsters were obtained and treated as described in Experiment 1, and 
surgeries were performed as described, as well.  oCRF was prepared and administered at 0.0 
or 1.0 nmol as described in Experiment 1. 
Apparatus 
The defensive withdrawal (DW) apparatus consisted of an open field with a 
withdrawal chamber inside it.  The open field was a 91x91x41 cm white acrylic box, open on 
top, with a dark grid on the floor whose squares measured 14.5 cm2 (36 squares total).  The 
withdrawal chamber, which sat near one corner of the open field, was a black acrylic box 
with one side open for the animal to enter and exit.  The withdrawal chamber measured 
32x13x20 cm in size with an inner measurement of 30.5x13x13 cm.  The field and chamber 
were cleaned with 100% ethanol after each animal was tested.  Lighting in the field during 
testing was indirect and measured approximately 800-lux white light. 
Procedures 
 Hamsters received vehicle or oCRF injection 30 min prior to testing.  To begin 
testing, hamsters were placed inside the DW chamber and a door was closed to keep them 
inside it until starting the observation.  The experiment began with the opening of the DW 
chamber, and the total duration of each test was 5 min.   
Data Acquisition and Analyisis 
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 In contrast to other rodents under anxiogenic conditions (e.g., bright light vs. dim 
light or following social defeat), Syrian hamsters display a decreased latency to enter the 
open field from the DW chamber.  Hamsters do exhibit rodent-typical decreases in overall 
locomotor activity inside an open field under anxiogenic (i.e., bright light) conditions (A.N. 
Faruzzi and K.L. Huhman, unpublished results).  In the current experiment, the mean latency 
to first enter the open field from the withdrawal chamber and overall locomotor activity were 
compared in hamsters receiving oCRF or vehicle. 
 Locomotor behavior, which is a measure of anxiety as well as of sedation (Crawley, 
1985; Costall et al., 1989; Lister, 1990; Menard and Treit, 1999), was recorded using 
EthoVision Video Tracking, Motion Analysis & Behavior Recognition System, v. 3.0 
(Noldus Information Technology b.v., Wageningen, The Netherlands).  This system uses 
video input and tracks the movement of the center of gravity of the animal in the arena and 
stores the data on a computer where the data can be analyzed for various behaviors of 
interest.  Total distance traveled was used to measure overall locomotor activity.  Latency (in 
sec) to exit the withdrawal chamber was recorded from videotape with a stopwatch by an 
observer blind to experimental conditions.  Data were analyzed using T-tests, and alpha was 
ascribed at p<0.05. 
RESULTS 
Experiment 1a   
 Two animals were excluded from analysis due to missed cannula placement.  Of the 
remaining animals, there was no effect of UCNII on behavior (F(4,48)=0.53 for submissive 
behavior and F(4,48)=2.68 for aggressive behavior, p>0.05).  Defeated hamsters receiving 
the high dose of oCRF prior to testing displayed significantly higher levels of submissive 
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behavior than did defeated hamsters receiving vehicle injections (F(2,36)=7.37, p<0.05).  
Nonsocial behavior was also significantly decreased in a dose-dependent manner 
(F(2,36)=14.91, p<0.05) in hamsters receiving oCRF.  There were also significant increases 
in submissive behavior in defeated hamsters versus non-defeated hamsters receiving vehicle 
(i.e., defeated hamsters displayed CD) and in defeated hamsters receiving oCRF versus non-
defeated hamsters receiving oCRF.  Finally, non-defeated hamsters receiving oCRF 
displayed significantly higher levels of aggressive behavior than did defeated hamsters 
receiving oCRF (F(1,17)=11.90, p<0.05), and there was also a trend toward increased 
aggressive behavior in non-defeated hamsters receiving oCRF compared to non-defeated 
controls (F(1,10)=4.07, p=0.07).  Means ± SEM for each group are displayed in Figure 1. 
Experiment 1b   
 Defeated hamsters receiving oCRF displayed significantly higher levels of 
submissive behavior than did controls (F(1,21)=6.88, p<0.05), and there was no significant 
interaction of ASVG.  A trend towards higher levels of aggressive behavior was observed in 
all 3 drug groups (ASVG+vehicle, vehicle+oCRF, and ASVG+oCRF) compared to the 
vehicle only group.  Additionally, there were no differences by group in animals that 
received ASVG/vehicle and oCRF/vehicle as a cocktail or as two separate injections.  Means 
± SEM for each group are displayed in Figure 2. 
Experiment 2   
 There was no significant difference in time to exit the withdrawal chamber in 
hamsters receiving oCRF compared to those receiving vehicle (t(22)=-0.50, p>0.05).  
Additionally, there was no significant difference in total locomotor behavior (t(18)=0.30, 
p>0.05). 
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DISCUSSION 
 The current data suggest that CRF modulates the expression of submissive behavior 
through its actions at CRFR1.  ICV injection of oCRF significantly enhanced the expression 
of CD in defeated hamsters.  Further, administration of ASVG did not block this effect, 
suggesting that oCRF is not working via spillover to CRFR2.  The current data also show a 
trend for oCRF to enhance the expression of aggressive behavior in previously undefeated 
hamsters.  In addition, the effects of oCRF appear not to be due to increases in general 
anxiety, as there was no effect of oCRF on DW or open field behaviors.  These results 
suggest that activation of CRFR1 modulates agonistic behavior, in general, and that the 
particular behavior that is affected is determined by the animal’s previous social experience. 
It is difficult to make conclusions about the role of CRFR2 in agonistic behavior.  The 
fact that UCNII had no effect on aggressive or submissive behavior suggests that CRFR2 
does not play a role in the modulation of CD by CRF.  However, because there is no 
information about binding of UCNII in hamster tissue, we cannot ignore the fact that we may 
have encountered a pharmacological problem and that UCNII does not adequately bind 
CRFR2 in hamsters.  Given the fact that other research in our lab has shown effects of the 
CRFR2-specific antagonist ASVG on reducing CD (Jasnow et al., 1999; Jasnow et al., 
2004b; Cooper and Huhman, 2005a), this possibility can not be dismissed.  It is also possible 
that activation of CRFR2 is necessary for CD, but that stimulation of this receptor is not 
sufficient to enhance CD.  Alternatively, it is possible that CRF receptors are involved in 
multiple aspects of the learning and display of situation-appropriate agonistic behaviors.  For 
example, CRFR2 could be involved in memory formation of social defeat while CRFR1 
could be involved modulating the actual display of appropriate behaviors given other factors 
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(e.g., previous social experience).  Either way, further investigation is needed before 
conclusions can be made about the role of CRFR2 in agonistic behavior in hamsters. 
Although the current results show only a trend for increased aggressive behavior in 
previously undefeated hamsters, we believe the data support the possibility of an excitatory 
effect of oCRF on aggressive behavior as we have demonstrated before (A.N. Faruzzi, M.A. 
Cooper, and K.L. Huhman, submitted).  The effect of oCRF and oCRF plus ASVG on 
aggressive behavior in non-defeated hamster groups actually formed bimodal distributions.  
Non-defeated hamsters receiving oCRF or oCRF plus ASVG could be divided into two 
distinct populations, one that displayed zero seconds of aggressive behavior and 200+ 
seconds of submissive behavior, and another that displayed 150+ seconds of aggressive 
behavior and zero seconds of submissive behavior.  The likely explanation for the 
unexpected display of submissive (and absence of aggressive) behavior in some of the “no-
defeat” hamsters is that they were previously subordinate before being singly-housed for the 
current study.  When hamsters are shipped from the breeder, they are group-housed, and they 
remain so after arriving at our institution until surgeries are performed.  During these periods 
of group housing, the hamsters routinely form social hierarchies.  Despite these opportunities 
for social experience, we have never had to prescreen hamsters for submissive/aggressive 
tendencies before conducting CD experiments because virtually all hamsters defeated using 
our typical training design subsequently show submissive behavior, regardless of their social 
experience prior to the experiment.  It is highly likely that the no-defeat groups of hamsters 
that showed increased submissive behavior instead of aggressive behavior were subordinate 
(i.e., had been defeated) prior to this experiment.  Further support for this argument is the fact 
that the levels of submissive behavior displayed by these hamsters were much higher than 
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that displayed by hamsters in the 5-min defeat groups.  This suggests that these hamsters 
have had more substantial defeats during their period of group-housing than the 5-min 
defeats that were used in the current experiment, causing them to display levels of 
submissiveness similar to those seen in hamsters that have experienced longer defeats 
(Jasnow et al., 2002).  The addition of an experiment where hamsters are pre-screened for 
submissive behavior prior to assignment to a no-defeat group would offer a definitive answer 
to whether oCRF increases aggressive behavior in previously undefeated hamsters.   
Overall, the current data support the hypothesis that activation of CRFR1 has potent 
enhancing effects on the expression of agonistic behavior in Syrian hamsters.  Further, this 
effect is modulated through an unknown mechanism by the hamster’s previous social 
experience (i.e., having been defeated or not), resulting in enhancement of either submissive 
behavior in previously subordinate hamsters or aggressive behavior in previously dominant 
hamsters, respectively.   
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FIGURE CAPTIONS 
Figure 3.1.  Means ± SEM of duration of submissive, aggressive, social and nonsocial 
behavior in defeated and non-defeated male hamsters receiving oCRF or vehicle before CD 
testing.  (planned comparisons were used to analyze this data- spurious comparisons are not 
illustrated; *p<0.05) 
 
Figure 3.2.  Means ± SEM of duration of submissive and aggressive behavior in a) non-
defeated and b) defeated male hamsters receiving ASVG/vehicle and oCRF/vehicle before 
CD testing.  (planned comparisons were used to analyze this data- spurious comparisons are 
not illustrated; *p<0.05) 
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ABSTRACT 
Corticotropin releasing factor (CRF) is located throughout the brain and has many 
behavioral and physiological effects.  Binding of agonists to CRF receptors can cause HPA 
axis activation, changes in levels of anxiety or depression, decreases in feeding as well as 
changes in blood pressure.  We have previously shown that binding of CRF to its receptors 
can have profound effects on agonistic behavior in Syrian hamsters.  CRF receptor 
distribution has been studied in a number of species, but the results have been inconsistent.  
No reports exist of CRF receptor distribution in hamster brain.  Therefore, the goal of this 
study was to provide an autoradiographical description of CRFR1&2 distributions throughout 
hamster brain.  The current data reveal a number of similarities and differences with previous 
reports of CRFR distributions in other species.  Additionally, these data provide specific 
information about CRFR1 and CRFR2 binding in functional subdivisions of the extended 
amygdala, which is of particular interest to those examining anxiety, fear responding and 
social conflict.   
 
KEYWORDS: autoradiography, mapping, extended amygdala, bed nucleus of the stria 
terminalis, hypothalamus 
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INTRODUCTION 
Corticotropin releasing factor (CRF) is a 41-amino acid peptide (Vale et al., 1983) 
located in the anterior pituitary and throughout the brain (Chappell et al., 1986; Eckart et al., 
1999; Eckart et al., 2002).  CRF has many behavioral and physiological effects, including 
increased anxiety-like responding, increased arousal and HPA axis activation, enhanced fear 
conditioning, and enhanced learning and memory in tasks such as visual discrimination, 
spatial learning, and inhibitory avoidance (Eckart et al., 1999; Landgraf, 2001; Dautzenberg 
and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002).  CRF is a 
critical component of the HPA axis response to stress, which ultimately has a number of 
effects including gluconeogenesis (to sustain the “flight or flight” response) and reduced 
inflammation, as well as feedback to the brain to control these peripheral responses.  In 
addition to its effects via HPA axis activation, CRF peptides and receptors are distributed 
throughout the brain (Bittencourt and Sawchenko, 2000; Lewis et al., 2001; Reyes et al., 
2001; Dautzenberg and Hauger, 2002; Eckart et al., 2002; Reul and Holsboer, 2002), 
suggesting a more direct role in behavior.    
There are currently two known receptor subtypes in the CRF family (CRFR1 and 
CRFR2).  Both subtypes are Gs protein-coupled and primarily activate adenylyl cyclase to 
increase cyclic AMP levels, though they are also associated with other signaling pathways 
(Dautzenberg and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002).  
Binding of agonists to CRFR1 causes HPA axis activation, increased anxiety, increased 
depression, decreased feeding, and decreased inflammatory response,  Binding of agonists to 
CRFR2 causes decreased feeding, decreased gastric emptying, decreased depression (except 
when administered into the LS), increased vasodilation, and decreased blood pressure 
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(Holsboer, 1999; Steckler and Holsboer, 1999; Arborelius et al., 1999; Eckart et al., 1999; 
Koob and Heinrichs, 1999; Takahashi, 2001; Dautzenberg and Hauger, 2002; Eckart et al., 
2002; Grammatopoulos and Chrousos, 2002).  The role that CRFR2 plays in anxiety-like 
behavior is not well understood, as both anxiogenic and anxiolytic actions have been reported 
(Eckart et al., 1999; Hashimoto et al., 2001; Takahashi et al., 2001; Dautzenberg and 
Hauger, 2002; Pelleymounter et al., 2002; Reul and Holsboer, 2002).   
There are studies mapping CRF receptor distribution in rat or rhesus monkey brain.  
In general, CRFR1 is found throughout the brain in areas important for sensory information 
processing and motor control, while CRFR2 is more restricted to subcortical regions (Reul 
and Holsboer, 2002).  CRFR1 mRNA expression has been found in sites including the 
anterior pituitary, cerebral cortex, cerebellum, amygdala, hippocampal formation, 
hypothalamus, areas of the brain stem, septum, BST, and olfactory bulb.  CRFR2 mRNA 
expression has been found in areas including the hippocampal formation, amygdala, LS, BST 
and areas of the hypothalamus and brainstem (Eckart et al., 1999; Bittencourt and 
Sawchenko, 2000; Dautzenberg and Hauger, 2002).   
Although there are numerous studies mapping CRF receptors, there is a high degree 
of variability in reported receptor distributions.  For example, some studies report minimal 
CRFR1 binding or CRFR1 mRNA expression in the Ce (Radulovic et al., 1999a) while 
others report high densities (Rybnikova et al., 2003).  There are also differences in reported 
distributions in the BST.  Rominger, et al., (Rominger et al., 1998) report high levels of 
CRFR2 binding in the BST while others report only moderate levels (Chalmers et al., 1995; 
Radulovic et al., 1999a).  There are many differences other than these (for more examples 
see: (Chalmers et al., 1995; Rominger et al., 1998; Radulovic et al., 1999a; Bittencourt and 
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Sawchenko, 2000; Rybnikova et al., 2003).  Many of these differences may be explained by 
differences in methodology.  Specifically, most of these studies have examined mRNA 
expression while only a few have directly examined receptor densities instead of, or in 
addition to, mRNA expression.  In one study, CRF receptor distribution in primates was 
examined using both autoradiography and in situ hybridization (ISH), and some dramatic 
disagreements between receptor binding and mRNA expression were found (Sanchez et al., 
1999).  While this comparison provides some useful information about CRF receptors (i.e., 
receptors are likely transported to these areas from elsewhere; (Sanchez et al., 1999) it 
highlights the problem that ensues from relying solely on mRNA expression to determine 
distribution of peptide binding sites. 
Another possible explanation for differences among reports of CRF receptor 
distribution is that the neuroanatomy used for localization of receptors or mRNA is 
inconsistent and imprecise.  There are no definitive boundaries between brain areas, and 
there are also numerous differences in the terminology used to delineate brain nuclei.  For 
example, an analysis of three studies mapping CRF receptors in rat brain revealed little 
agreement in the neuroanatomical localization of receptors in the BST.  Of the two that 
mapped expression in the BST, one examined only the medial division (Chalmers et al., 
1995), while the other examined distribution throughout the BST as divided into 
anteromedial, anterolateral, oval nucleus, and the posterior parts (Bittencourt and 
Sawchenko, 2000).  In contrast, experiments investigating the role of the BST in conditioned 
and unconditioned fear have focused primarily on the dorsal and ventral parts of the medial 
and lateral divisions (Walker and Davis, 1997).  Therefore, currently available data on the 
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distribution of CRF receptors in the BST do not provide adequate information about the 
localization of CRF receptors in subdivisions important for fear and anxiety-like responses.   
Our laboratory studies the role of CRF receptors in agonistic behavior in Syrian 
hamsters (Mesocricetus auratus).  We have shown that ICV and intra-BST injections of 
CRFR antagonists attenuate forms of agonistic behavior and that ICV injection of CRFR 
agonists enhance agonistic behavior, but we do not know where CRF acts to have these 
effects.  We are particularly interested in CRFR distributions in the extended amygdala as 
well as in other areas important for emotionality, arousal, and agonistic behavior, such as the 
hypothalamus, PAG, and the DR.  The current study provides an autoradiographical 
description of CRFR1&2 distributions throughout the hamster brain. 
METHODS 
Subjects   
Male Syrian hamsters were purchased from Charles River Laboratories.  
Experimental animals were three to four months old and weighed 120-140 g at the start of the 
study.  The animals were individually housed for one week prior to sacrifice in a temperature 
controlled (20ºC ± 2º) colony room and were maintained on a 14:10h light:dark cycle.  All 
animals were housed in polycarbonate cages (20 x 40 x 20 cm) with corncob and cotton 
bedding materials and wire mesh tops.  Food and water were available ad libitum, and cages 
were not changed while they were individually housed.  Animals were handled daily during 
the week prior to sacrifice in order to habituate them to the stress of being handled by the 
experimenter.  Tissue from four hamsters was ultimately used for autoradiography.  All 
procedures and protocols were approved by the Georgia State University Institutional Animal 
Care and Use Committee.   
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CRF Receptor Autoradiography   
Autoradiography procedures were performed similarly to those described previously 
(Sanchez et al., 1999; Lim et al., 2005) and are described briefly here.  Receptor 
autoradiography was performed with [125I-Tyr0]-sauvagine, which has high affinity for both 
CRFR1 (Kd=0.2-0.4 nM) and CRFR2 (Kd=0.1-0.3 nM) (Grigoriadis et al., 1996; Primus et 
al., 1997).  To identify CRFR2 binding sites, [125I-Tyr0]-sauvagine was combined with an 
excess of unlabeled CP-154,526, a CRFR1-selective antagonist (Schulz et al., 1996).  To 
identify CRFR1 binding sites, optical density readings of total CRFR binding minus specific 
CRFR2 were used.  The subtraction technique is further described below in Data Analysis. 
Animals were rapidly decapitated, and their brains were removed and flash-frozen on 
dry ice before being stored in -80ºC.  Brains were sliced on a cryostat at 20 µm, and sections 
were thaw-mounted onto Superfrost Plus slides (Fisher, Pittsburgh, PA) and stored at -80ºC 
until assayed.  Five sets of continuous sections were collected from prefrontal cortex through 
hindbrain.  Three adjacent sets of sections were processed for CRFR total binding, CRFR2 
binding, and CRFR nonspecific binding, similar to previously described protocols (Sanchez 
et al., 1999; Lim et al., 2005). 
Slides were thawed at room temperature until dry and fixed for 2 min in 0.1% 
paraformaldehyde-PBS solution (pH 7.4).  Slides were then rinsed twice in 50 mM Tris base 
(pH 7.4) solution for 10 min each, then incubated in tracer for 60 min.  Tracer buffer 
consisted of a 50 mM Tris base, 10 mM MgCl, 0.1% bovine serum albumin, 0.05% 
bacitracin, plus 0.2 nM [125I-Tyr0]-sauvagine (PerkinElmer/NEN, Boston, MA), which binds 
both CRFR1 and CRFR2.  Slides were then rinsed with 50 mM Tris base plus 10 mM MgCl 
(pH 7.4) for 3x5 min, plus 30 min with stirring on a stir plate with a magnetic bar.  Slides 
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were then dipped in deionized H2O, blown dry with cool air, and apposed to Kodak MR film 
for 72 hr with [125I] microscale standards (PerkinElmer/NEN).  Representative brain sections 
are shown in Figure 1. 
CRFR2 Autoradiography   
An adjacent set of slides were processed at the same time for CRFR2 receptor sites.  
CRFR2 binding was measured as described above, with the addition of unlabeled CP-
154,526-1 (butyl-[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]-pyrimidin-4-
yl]-ethylamine), a selective CRFR1 antagonist, which was kindly provided by Michael J. 
Owens, Ph.D.  The concentration of CP-154,526 used in this study was 1 µM, which 
competes with [125I-Tyr0]-sauvagine for CRFR1, but not CRFR2, binding sites because the Ki 
for inhibition of binding by [125I-Tyr0]-sauvagine to CRFR2 is greater than 10 µM (Schulz et 
al., 1996).  This protocol has been successfully used to assay rat, monkey, and vole tissue 
(Sanchez et al., 1999; Skelton et al., 2000; Lim et al., 2005).  Representative brain sections 
are shown in Figure 1.   
CRFR Nonspecific Binding 
A third set of adjacent slides were processed for nonspecific binding for both CRFR1 
and CRFR2 as described above in CRF Receptor Autoradiography, with the addition of 1 
µM cold sauvagine (American Peptide, Sunnyvale, CA) to the tracer buffer containing the 
[125I-Tyr0]-sauvagine to compete with CRFR1 and CRFR2 binding sites as described 
previously (Sanchez et al., 1999; Lim et al., 2004).   
Data Analysis   
The fourth and fifth sets of adjacent slides were stained for thionin and 
acetylcholinesterase (AChE), respectively, to better delineate brain regions (specifically 
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AChE for amygdalar subnuclei) for image analysis (see Figures 2 and 3).  Total CRFR 
binding, CRFR2 binding and nonspecific binding were quantified using MCID Basic v. 7.0 
(Imaging Research Inc., Ontario, Canada).  AChE- and thionin-stained sections were used to 
delineate the borders of brain regions of interest before sampling.  Bilateral measurements 
were averaged for each brain region across two or three sections.  Optical density readings 
were measured in decompositions per minute per milligram tissue (dpm/mg) based on a 
known set of [125I] microscales exposed on each film.   
Specific CRFR2 binding values were obtained by subtracting background values from 
each section and then nonspecific binding values from [125I-Tyr0]-sauvagine binding in the 
presence of 1 µM CP-154,526.  Specific CRFR1 binding values were calculated by 
subtracting background values from each section and nonspecific binding, and then 
subtracting corrected CRFR2 binding. 
Statistics  
The following equations were used to obtain the corrected values for each CRFR1 
and CRFR2: (R2-background-NScor)=R2 corrected value; (R1R2-background-NScor-
R2corrected value)=R1 corrected value (NScor=NS-NSbackground).  The corrected values 
for each region were averaged for each animal, and an overall mean and standard deviation 
was calculated across animals for each brain region. 
Final values for each brain region were assigned quantitative values according to 
respective percentile distributions of averaged, corrected values for all regions measured.  
Optical density was expressed as: ++++, very dense binding (≥65%); +++, dense binding 
(<65%, ≥45%); ++, moderate binding (<45%, ≥25%); +, light binding (<25%, ≥5%); and +/-, 
sparse or no binding (<5%).   
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Photomicrograph Production Details   
Digital images were obtained from film autoradiograms using MCID Basic v. 7.0 
(Imaging Research Inc., Ontario, Canada).  Digital images of AChE- or thionin-stained 
sections were taken using a Hewlett-Packard Scanner.  Images were then imported into 
Adobe Photoshop 7.0 (Adobe Systems, San Jose, CA), cropped, and minimally adjusted for 
brightness and contrast in order to clarify the scientific point of interest.  Adobe Photoshop 
7.0 was also used to add all image text and arrows.  
RESULTS 
Figure 1 shows CRFR distribution throughout the hamster brain.  Panes labeled with 
“a” display CRFR1&2 distribution, and panes labeled with “b” show the corresponding 
CRFR2 distribution.  Thionin or AChE stained sections are also displayed to aid in 
localization.  Table 2 lists the distribution of CRFR1 and CRFR2 throughout a number of 
brain sites.  This list highlights many areas related to emotionality and to social and agonistic 
behavior, which are of particular interest to our laboratory, and is not meant to be exhaustive.  
The following describes distributions of CRFR1 and CRFR2 in these areas. 
Distribution of CRFR1   
CRFR1 were distributed widely throughout the cortex (see Figure 1).  Some 
particular prefrontal cortical areas included the Cg (Mean ± SEM dpm/mg; 
Cg1=718.39±11.03, Cg2=934.83±12.48), the IL (831.01, n=1), and the PrL (1442.84, n=1).  
CRFR1 were also spread throughout the CPu (340.57±7.85) with a higher density in the 
ventral striatum (610.49±9.54).  The LS and the BST had light CRFR1 binding 
(LS=195.30±7.64; BSTA=200.24±6.54, BSTPM=147.70±7.08, BSTPI=244.68±8.38, 
BSTPL=273.65±10.40).  The AStr had moderate CRFR1 binding (843.94±14.84). 
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CRFR1 binding was spread throughout the amygdala, with the exception of the Ce, 
which had sparse binding (112.91±6.75).  The La (anterior) and MeA had moderate binding 
(668.35±11.65 and 823.09±12.31, respectively), while the La (posterior), BLA (anterior and 
posterior), I, and MeP showed moderate to light binding (464.97±9.69, 344.37±8.22 and 
293.82±8.95, 283.06±8.33, and 276.17±7.97, respectively).  However, there was dense 
binding in the BMA (1228.80±14.92), BLV (1388.75±20.75), BMP (1455.25±16.62), and 
PMCo (1692.72±12.77), and very dense binding in the PLCo (1824.26±17.67). 
There was sparse binding in all measured areas of the hippocampus 
(CA1=46.51±3.37, CA2-3=28.60±3.38, DG=73.74±4.10) except for the S, which had light 
binding (292.50±5.59).  The hypothalamus also showed moderate to light binding in areas 
including the AH (230.74±5.65), LH (177.53±3.76), Pa (138.34±66.23), SCN (158.48±5.87) 
and VMHL (173.94±5.53), and sparse binding in the VMHM (106.21±4.84) and Arc 
(81.58±4.14).   
The SuG had very dense CRFR1 binding (2660.16±23.39).  There was light binding 
in the PAG (209.47±7.60) and DR (234.33±10.51), and there was sparse binding in the MnR 
(130.10±6.18) and PMnR (66.99±4.64).  The CG and NTS also had sparse binding 
(98.44±5.72 and 41.13±3.73, respectively).  One area that had moderate CRFR1 binding 
(639.98±16.15) is as of yet unidentified, though when compared to the hamster atlas (Morin 
and Wood, 2001) it appears to overlap with areas labeled as pre-, para-, and postsubiculum 
(illustrated with arrow in pane 33a of Figure 1).   
Distribution of CRFR2   
CRFR2 were densely distributed throughout choroid plexus and therefore showed 
high binding in areas like the lateral ventricles (see arrow in panes 8a and 8b of Figure 1).  
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CRFR2 was sparsely distributed throughout the cortex or striatum (e.g., Cg1=76.73±4.27, 
Cg2=113.84±4.91, IL=115.85 (n=1), PrL=103.89 (n=1), CPu=89.26±5.20, and ventral 
striatum=99.84±5.38).  There was dense binding (1959.10±20.95) in the LS.  There was 
sparse to no binding in the BST (BSTA=137.29±5.94, BSTPI=68.62±4.49, 
BSTPM=2.75±1.17) except in the BSTPL, which had light binding (197.37±7.63), though 
binding was stronger in very discreet areas of the BSTPL (see arrow in panes 7a and 7b of 
Figure 1).  The AStr showed moderate CRFR2 binding (971.72±10.08). 
There was CRFR2 binding throughout the amygdala, with the exception of the MeA 
and MeP, which showed sparse binding (157.75±5.29 and 91.95±5.34, respectively).  There 
was light to moderate binding in the Ce (276.95±2.45), BMA (302.92±5.05), La (posterior; 
484.34±6.74), BLA (posterior; 514.74±5.71), BMP (526.66±8.82), BLA (anterior; 
597.54±4.65) and BLV (642.62±9.48).  The La (anterior) and PMCo had moderate binding 
(1617.92±8.61 and 1367.38±9.68, respectively), and the intercalated nucleus had dense 
binding (2403.82±9.95).  Finally, there was very dense CRFR2 binding in the PLCo 
(3953.02±21.26).   
As with CRFR1, there was sparse to no CRFR2 binding in the hippocampus 
(CA1=29.39±2.75, CA2-3=26.99±2.33, DG=31.36± 2.56, S=5.48±2.61).  Much of the 
hypothalamus showed sparse binding in areas including the Arc (41.52±3.18), Pa 
(46.40±2.88), AH (149.93±5.66), and SCN (154.68±4.69).  There were slightly higher levels 
of binding in the VMHM (206.55±4.27), VMHL (222.09±5.07), and LH (290.07±6.03). 
There was sparse CRFR2 binding in the SuG (108.11±5.26).  The PAG showed light 
binding (307.39±9.79), as did the DR (579.91±8.57), PMnR (219.09±2.55), and the NTS 
(which was approaching moderate; 696.99±6.75).  There was sparse binding in the MnR 
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(155.26±2.80) in the CG (29.23±2.14).  Finally, the unidentified area described above as 
overlapping with the areas labeled as pre-, para-, and postsubiculum on the hamster atlas 
(Morin and Wood, 2001) showed very dense CRFR2 binding (4308.08±22.26; illustrated 
with arrow in pane 33b of Figure 1). 
DISCUSSION 
The current study is the first to illustrate the distribution of CRF receptors throughout 
hamster brain.  The current data reveal a number of similarities and differences with previous 
reports of CRFR distributions in other species.  Additionally, it provides specific information 
about CRFR1 and CRFR2 binding in functional subdivisions of the extended amygdala, 
which is of particular interest to those examining anxiety, fear responding and social conflict.   
Although comparing our results with existing reports of CRFR distribution is difficult 
due to the lack of consistent techniques (as described in detail in the Introduction), it is 
possible to make some interesting comparisons.  For example, the density of CRFR1 and 
CRFR2 in the LS in the current study is consistent with reports of CRFR1 and CRFR2 
mRNA expression in other studies (low CRFR1 and high CRFR2; Chalmers et al., 1995; 
Radulovic et al., 1999a; Bittencourt and Sawchenko, 2000; Rybnikova et al., 2003).  
Receptor distribution was also consistent with most reports of little to no mRNA expression 
in the Ce (Radulovic et al., 1999a; Bittencourt and Sawchenko, 2000), with the exception of 
one study reporting high CRFR2 mRNA expression (Rybnikova et al., 2003).  On the other 
hand, moderate to high CRFR2 mRNA expression has been reported in the MeA (Chalmers 
et al., 1995; Radulovic et al., 1999a; Bittencourt and Sawchenko, 2000; Rybnikova et al., 
2003), though the present study found very minimal CRFR2 binding.  Additionally, despite 
the differences among reports as to the division of the hippocampus, there is still a very 
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obvious difference in hippocampal binding in the current study overall compared to other 
studies.  While others reported varying mRNA expression (Chalmers et al., 1995; Radulovic 
et al., 1999a; Bittencourt and Sawchenko, 2000; Rybnikova et al., 2003), the current study 
demonstrates only sparse binding throughout most of the hamster hippocampus.  Because the 
four other studies compared mRNA expression only, it is possible that those receptors are 
transported elsewhere or that post-transcriptional changes (resulting from stress, for example) 
are necessary for higher densities of functional CRF receptors in hamsters. 
There are also some specific differences between the current and existing studies in 
CRFR1 and CRFR2 distribution in the hypothalamus.  The current results are consistent with 
a previous report of little to no CRFR1 or CRFR2 mRNA expression in the Arc (Rybnikova 
et al., 2003) but disagree with another study reporting moderate mRNA expression 
(Bittencourt and Sawchenko, 2000).  Similarly, while other studies report CRFR2 mRNA 
expression to be high in the VMH (Chalmers et al., 1995; Radulovic et al., 1999a; 
Bittencourt and Sawchenko, 2000; Rybnikova et al., 2003) and moderate in the Pa (Chalmers 
et al., 1995; Radulovic et al., 1999a; Bittencourt and Sawchenko, 2000), the current study 
reveals moderate and low CRFR2 binding in these areas, respectively.  
CRF receptors have been shown to have a role in HPA axis activation, anxiety, 
feeding, learning and memory, conditioned defeat, and conditioned and unconditioned fear 
responses (Liang et al., 1992; Lee and Davis, 1997; Birnbaum and Davis, 1998; Jasnow et 
al., 1999; Eckart et al., 1999; Landgraf, 2001; Faruzzi and Huhman, 2001; Dautzenberg and 
Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 2002; Toufexis et al., 
2004; Cooper and Huhman, 2005a; Cooper and Huhman, 2005b).  Consistent with these 
findings, CRFR1 and/or CRFR2 were found in Syrian hamster brain in many regions 
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involved in these behaviors, such as prefrontal cortex, subdivisions of the BST and 
amygdala, the DR, and the LS.  It has also been suggested that CRFR2 may act specifically 
to oppose or modulate responses mediated by CRFR1 (Reyes et al., 2001; Grammatopoulos 
and Chrousos, 2002).  The current data may provide support for this hypothesis because they 
reveal overlap of CRFR1 and CRFR2 in several subcortical areas.  
Of particular interest, given our data on conditioned defeat, was the distribution of 
CRFR1 and CRFR2 in the extended amygdala.  We have previously shown that non-specific 
and CRFR2-specific antagonists attenuate the acquisition and expression of conditioned 
defeat in hamsters when given into the BST (Cooper and Huhman, 2005a) but not into the Ce 
(Jasnow et al., 2004b).  It was therefore important to characterize CRFR2 distribution within 
subregions of the BST in order to suggest specific sites of action and to validate proposed 
pathways (like that described in (Jasnow et al., 2004b).  The current results indicate the 
existence of discreet densities of CRFR2 in the BSTPL that may be mediating effects of CRF 
antagonists on conditioned defeat.  Consistent with this idea, Cooper and Huhman (Cooper 
and Huhman, 2005a) have demonstrated reductions in submissive behavior following 
injection of CRFR antagonist specifically targeted at the BSTPL.   Also, because ongoing 
studies in our laboratory have suggested a role for the DR in the acquisition and expression 
of conditioned defeat (M.A. Cooper, personal communication) as well, it was of interest to 
characterize the distribution of CRF receptors in this region.  In the current study, both 
CRFR1 and CRFR2 binding were observed in the DR, with a higher density of CRFR2.  
Finally, we have previously shown that ICV injection of a specific CRFR1 agonist increases 
the expression of agonistic behaviors in hamsters, suggesting a role for CRFR1 in areas 
important for modulating aggressive and defensive behaviors (Faruzzi, Zelinski, Tenenbaum, 
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and Huhman, submitted).  The fact that CRFR1 binding was observed in areas such as the 
PAG, AH, LH, CG, and other regions related to aggression and defense systems will help 
pinpoint particular sites for further investigation of these effects.   
Overall, CRFR1 is found throughout hamster brain while CRFR2 appears to be more 
confined to subcortical areas.  While this finding is in agreement with most studies reporting 
CRF receptor distributions, there are many region-specific differences in distribution 
between hamster and rat and possibly differences between mRNA expression and receptor 
binding.  The mapping presented in the current study provides a specific resource for the 
investigation of the role of CRF receptors in Syrian hamster behavior as well as contributes 
to findings obtained from investigation of other species. 
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Figure 4.1.  CRFR total binding (labeled with “a”) and CRFR2 binding (labeled with “b”) 
throughout hamster brain from prefrontal cortex to cerebellum (numbered 1-38).  Pane 
numbers correspond to numbers on adjacent thionin-stained slides in Figure 4.2 and AChE-
stained slides in Figure 4.3. 
 
Figure 4.2.  Adjacent thionin-stained slides to autoradiography slides.  Numbers correspond 
to numbers in Figures 4.1 and 4.3. 
 
Figure 4.3.  Adjacent AChE-stained slides of the extent of the amygdala.  Numbers 
correspond to numbers in Figures 4.1 and 4.2. 
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Table 4.1.  Abbreviations 
Region Abbreviation
Cortex  
 cingulate cortex 1 Cg1 
 cingulate cortex 2 Cg2 
 prelimbic cortex PrL 
 infralimbic cortex IL 
Striatum  
 caudate putamen CPu 
Lateral Septum LS 
Bed Nucleus of the Stria Terminalis  
 anterior BSTA 
 posteromedial BSTPM 
 posterointermediate BSTPI 
 posterolateral BSTPL 
Amygdalostriatal Transition Area AStr 
Amygdala  
 anterior lateral La 
 anterior medial MeA 
 intercalated I 
 anterior basolateral BLA 
 central Ce 
 anterior basomedial BMA 
 posterior lateral La 
 posterior medial MeP 
 ventral basolateral BLV 
 posterior basomedial BMP 
 posterior basolateral BLA 
 posterior lateral cortical PLCo 
 posterior medial cortical PMCo 
Hippocampus  
 dentate gyrus DG 
 subiculum S 
Hypothalamus  
 anterior AH 
 lateral LH 
 paraventricular Pa 
 suprachiasmatic SCN 
 lateral ventromedial VMHL 
 medial ventromedial VMHM 
 arcuate Arc 
Superior Colliculus, superficial gray layer SuG 
Periaqueductal Gray PAG 
Raphe  
 median raphe MnR 
 paramedian raphe PMnR 
 dorsal raphe DR 
Central Gray CG 
Nucleus of the Solitary Tract Sol 
 
Abbreviations match those used in A stereotaxic atlas of the golden 
hamster brain (Morin and Wood, 2001). 
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Table 4.2. 125I-sauvagine binding to CRFR1 and 
CRFR2 in Syrian hamster brain 
Region CRFR1 CRFR2 
Cortex   
cingulate cortex 1 ++ +/-
cingulate cortex 2 ++ +/-
prelimbic cortex +++ +/-
infralimbic cortex ++ +/-
Striatum   
caudate putamen + +/-
ventral striatum + +/-
Lateral Septum + +++ 
Bed Nucleus of the Stria Terminalis   
anterior + +/-
posteromedial + +/-
posterointermediate + +/-
posterolateral + +
Amygdalostriatal Transition Area ++ + 
Amygdala   
anterior lateral ++ ++
anterior medial ++ +/-
intercalated + +++
anterior basolateral + +
central +/- +
anterior basomedial +++ +
posterior lateral + +
posterior medial + +/-
ventral basolateral +++ +
posterior basomedial +++ +
posterior basolateral + +
posterior lateral cortical ++++ ++++
posterior medial cortical +++ ++
Hippocampus   
CA1 +/- +/-
CA2-3 +/- +/-
dentate gyrus +/- +/-
subiculum + +/-
Hypothalamus   
anterior + +/-
lateral + +
paraventricular + +/-
suprachiasmatic + +/-
lateral ventromedial + +
medial ventromedial +/- +
arcuate +/- +/-
Superior Colliculus, superficial gray layer ++++ +/- 
Periaqueductal Gray + + 
Raphe   
median raphe +/- +/-
paramedian raphe +/- +
dorsal raphe + +
Central Gray +/- +/- 
Unidentified* ++ ++++ 
Nucleus of the Solitary Tract +/- + 
 
 
CRFR1 and CRFR2 distribution throughout various brain sites as 
determined from optical density measurements.  Values are presented 
according to percentile distributions: ++++ very dense binding 
(≥65%), +++ dense binding (<65%, ≥45%), ++ moderate binding 
(<45%, ≥25%), + light binding (<25%, ≥5%), +/- sparse or no binding 
(<5%).   
 
*Appears to overlap with areas labeled as pre- and post-subiculum on 
a Syrian hamster atlas (Morin and Wood, 2001), but positive 
identification of this site is yet unknown.   
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ABSTRACT 
 When a male Syrian hamster is defeated in an agonistic encounter, it will 
subsequently fail to display territorial aggression and will, instead, display submissive 
behavior in the presence of a non-aggressive intruder, a response known as conditioned 
defeat (CD).  Previous research in our laboratory has suggested roles for corticotropin 
releasing factor (CRF) receptor subtypes in the acquisition and expression of CD.  The 
current study investigated whether CRF receptor binding in brain sites important for fear 
conditioning, expression of unconditioned fear, and defensive behavior.  Tissue was collected 
at two time-points following defeat (24 and 72 hr), and autoradiography was performed for 
CRF type 1 and type 2 receptor binding.  Analysis revealed no significant differences 
between winners, defeated hamsters, or controls at either time point in any brain area 
investigated.  While it is acknowledged that an exhaustive examination of autoradiography 
results may reveal a yet-undiscovered effect, it is likely that alterations following social 
interaction reflect a change in peptide availability than receptor binding.  Finally, directions 
for further investigation are discussed.   
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INTRODUCTION 
When a male Syrian hamster (Mesocricetus auratus) is defeated in an agonistic 
encounter, it will subsequently fail to display any territorial aggression in future social 
encounters.  A defeated hamster will instead subsequently show increased submissive 
behavior, even when these encounters occur in its own home cage against a smaller, non-
aggressive intruder (Potegal et al., 1993).  This change in behavior is termed conditioned 
defeat (CD).  In addition to this striking behavioral change, defeated hamsters exhibit 
increased plasma adrenocorticotropic hormone (ACTH) and cortisol (CORT) concentrations 
following a social encounter (Huhman et al., 1990; Huhman et al., 1991; Huhman et al., 
1992), whereas dominant hamsters do not.  These behavioral and physiological changes have 
led to investigation of CD as both a model of stress and of fear conditioning.  These 
investigations have suggested, among other things, a role for corticotropin releasing factor in 
the expression and possibly the acquisition of CD.   
Corticotropin releasing factor (CRF) is a 41-amino acid peptide (Vale et al., 1983) 
located in the anterior pituitary and throughout the brain (Chappell et al., 1986; Eckart et al., 
1999; Eckart et al., 2002).  It has many behavioral and physiological effects, including 
increased anxiety-like responding, increased arousal and hypothalamo-pituitary-adrenal 
(HPA) axis activation (Jezova et al., 1999).  CRF is a critical component of the HPA axis 
response to stress, which has a number of effects including gluconeogenesis (to sustain the 
“flight or flight” response), reduced inflammation, as well as negative feedback to the brain 
to control these peripheral responses.  In addition to the critical role of CRF in the HPA axis 
response to stress, CRF peptides and receptors are distributed throughout the brain 
(Bittencourt and Sawchenko, 2000; Lewis et al., 2001; Reyes et al., 2001; Dautzenberg and 
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Hauger, 2002; Eckart et al., 2002; Reul and Holsboer, 2002), suggesting a wider role for this 
peptide.  Consistent with this view, numerous studies have demonstrated extrahypothalamic 
actions of CRF in various fear conditioning paradigms (Steckler and Holsboer, 1999; 
Radulovic et al., 1999b; Takahashi, 2001) and in learning and memory tasks such as visual 
discrimination, spatial learning, and inhibitory avoidance (Eckart et al., 1999; Landgraf, 
2001; Dautzenberg and Hauger, 2002; Eckart et al., 2002; Grammatopoulos and Chrousos, 
2002).   
Previous research in our laboratory (Jasnow et al., 1999; Jasnow et al., 2004b; 
Cooper and Huhman, 2005a) has indicated that nonselective CRF receptor (CRFR) 
antagonists can attenuate the expression of conditioned defeat.  We have also shown that ICV 
administration the nonselective receptor agonist rat/human CRF enhances CD and possibly 
territorial aggression in hamsters that have not previously been defeated (A.N. Faruzzi, M.A. 
Cooper, and K.L. Huhman, submitted).  In addition, we have reported that administration of 
the nonspecific CRF receptor antagonist D-Phe CRF (12-41) or the CRFR2-specific 
antagonist antisauvagine-30 attenuates the expression of CD (Jasnow et al., 1999; Jasnow et 
al., 2004b; Cooper and Huhman, 2005a), while the CRFR1 specific antagonist CP-154,526 
does not (Jasnow et al., 1999; Cooper and Huhman, 2005a).   
After an acute defeat, the behavioral change observed in hamsters is noticeable 24 
hours later and is long-lasting (Huhman et al., 2003).  It would therefore be reasonable to 
assume that there are long-term changes occurring in the brain that support the prolonged 
behavioral response known as conditioned defeat.  It is already clear that CRF transmission 
plays a role in modulating the acquisition and expression of CD, so it is possible that some of 
these changes are occurring at the level of CRFRs.  The purpose of the current experiment 
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was to determine whether there are differences in CRF receptor binding at several time-
points post-defeat in dominant, subordinate, and isolated hamsters, and if those differences 
are reflective of changes in CRFR1 or CRFR2 receptor densities. 
METHODS 
Subjects 
Male Syrian hamsters were purchased from Charles River Laboratories.  
Experimental animals were three to four months old and weighed 120-140 g at the start of the 
study.  These animals were individually housed for 10 days to two weeks prior to testing in a 
temperature controlled (20ºC ± 2º) colony room and were maintained on a 14:10h light:dark 
cycle.  Older animals that weighed 160-180g were housed individually and used as resident 
aggressors for defeats.  Younger animals (two months) that weighed 100-110g were group-
housed (five animals per cage) and were used as non-aggressive intruders during social 
interaction.  All animals were housed in polycarbonate cages (20 x 40 x 20 cm) with corncob 
and cotton bedding materials and wire mesh tops.  Food and water were available ad libitum.  
The cages of experimental animals and resident aggressors were not changed for at least one 
week prior to testing to allow the animals to scent mark their territory.  All testing and tissue 
collection occurred within the first three hours after the onset of the dark phase of the 
light:dark cycle in order to minimize circadian variation of the dependent measures.  All 
experimental animals were handled daily for one week prior to training in order to habituate 
them to the stress of being handled by the experimenter.  Different groups of hamsters were 
used for each experiment.  All procedures and protocols were approved by the Georgia State 
University Institutional Animal Care and Use Committee.   
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Social Interaction 
 Hamsters were weight-matched into three groups: winners, controls, and defeats.  
Social interaction for the winners group consisted of one 15-min interaction with a smaller, 
group-housed intruder.  The resident-intruder model was chosen over a neutral arena to 
increase the chance of attaining each group’s desired outcome, and it most closely resembles 
the conditioned defeat model.  During the 15-min encounter, the resident experimental 
animal attacked the intruder and attained dominance.  Social interaction for the defeat group 
consisted of one 15-min interaction as an intruder in the cage of a resident aggressor.  A 
single 15-min social defeat is sufficient to produce CD (Potegal et al., 1993).  Treatment for 
control animals consisted of being placed in a resident aggressor’s cage alone for 15-min, 
during which time the experimental hamster is exposed to the resident aggressor’s bedding 
but is not attacked. 
Tissue Collection 
 After behavioral training, animals were sacrificed by rapid decapitation.  Weight-
matched winner, control, and defeat groups were each divided into two tissue collection 
groups.  According to group assignment, tissue was collected at either 24 or 72 hours post-
training.  24-hr post-training was chosen because that is when CD is observed, suggesting 
that any changes in receptor densities that may occur to support CD may have occurred by 
this time point.  72-hr was chosen because CD has been shown to occur up to 33 days post-
defeat (Huhman et al., 2003), so long-term changes in receptors may not be evident until a 
later time point. 
Following decapitation brains were extracted and flash frozen on dry ice before being 
stored in a -80°C freezer.  Tissue was sliced on a cryostat at 20 µm.  Five sets of sequential 
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sections targeted at specific points in the brain were collected and mounted on Fisher 
Superfrost slides and stored in a -80°C freezer until autoradiography was performed.  Two 
adjacent sets of sections were processed each for CRFR total binding or CRFR2 binding, 
similar to previously described protocols (Sanchez et al., 1999; Lim et al., 2005), and 
remaining sets were stained or reserved.  
CRF Receptor Autoradiography   
Autoradiography procedures were performed similarly to those described previously 
(Sanchez et al., 1999; Lim et al., 2005) and are described briefly here.  Receptor 
autoradiography was performed with [125I-Tyr0]-sauvagine, which has high affinity for both 
CRFR1 (Kd=0.2-0.4 nM) and CRFR2 (Kd=0.1-0.3 nM) (Grigoriadis et al., 1996; Primus et 
al., 1997).  To identify CRFR2 binding sites, [125I-Tyr0]-sauvagine was combined with an 
excess of unlabeled CP-154,526, a CRFR1-selective antagonist (Schulz et al., 1996).  To 
identify CRFR1 binding sites, optical density readings of total CRFR binding minus specific 
CRFR2 were used.  The subtraction technique is further described below in Data Analysis. 
Slides were thawed at room temperature until dry and lightly fixed for 2 min in 0.1% 
paraformaldehyde-PBS solution (pH 7.4).  Slides were rinsed twice in 50 mM Tris base (pH 
7.4) solution for 10 min each, and then incubated in tracer for 60 min.  Tracer buffer 
consisted of a 50 mM Tris base, 10 mM MgCl, 0.1% bovine serum albumin, 0.05% 
bacitracin, plus 0.2 nM [125I-Tyr0]-sauvagine (PerkinElmer/NEN, Boston, MA), which binds 
both CRFR1 and CRFR2.  Following incubation, slides were rinsed with 50 mM Tris base 
plus 10 mM MgCl (pH 7.4) for 3x5 min, plus 30 min with stirring on a stir plate with a 
magnetic bar.  Slides were then dipped in deionized H2O, blown dry with cool air, and 
apposed to Kodak MR film for 72 hr with [125I] microscale standards (PerkinElmer/NEN).   
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CRFR2 Autoradiography   
An adjacent set of slides were processed at the same time for CRFR2 receptor sites.  
CRFR2 binding was measured as described above, with the addition of unlabeled CP-
154,526-1 (butyl-[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]-pyrimidin-4-
yl]-ethylamine), a selective CRFR1 antagonist, which was kindly provided by Michael J. 
Owens, Ph.D.  The concentration of CP-154,526 used in this study was 1 µM, which 
competes with [125I-Tyr0]-sauvagine for CRFR1, but not CRFR2, binding sites because the Ki 
for inhibition of binding by [125I-Tyr0]-sauvagine to CRFR2 is greater than 10 µM (Schulz et 
al., 1996).  This protocol has been successfully used to assay rat, hamster, monkey, and vole 
tissue (Sanchez et al., 1999; Skelton et al., 2000; Lim et al., 2005).  
Data Analysis   
Third and fourth sets of adjacent slides were stained for AChE and thionin to better 
delineate brain regions (specifically AChE for amygdalar subnuclei) for image analysis.  
Total CRFR binding, CRFR2 binding and nonspecific binding were quantified using MCID 
Basic v. 7.0 (Imaging Research Inc., Ontario, Canada).  AChE- and thionin-stained sections 
were used to delineate the borders of brain regions of interest before sampling.  
Measurements were averaged for each brain region across two or three sections.  Optical 
density readings were measured in decompositions per minute per milligram tissue (dpm/mg) 
based on a known set of [125I] microscales exposed on each film.   
Specific CRFR2 binding values were obtained by subtracting background values from 
each section and then nonspecific binding values from [125I-Tyr0]-sauvagine binding in the 
presence of 1 µM CP-154,526.  Specific CRFR1 binding values were calculated by 
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subtracting background values from each section and nonspecific binding, and then 
subtracting corrected CRFR2 binding 
Statistics  
The following equations were used to obtain the corrected values for each CRFR1 
and CRFR2: (R2-background)=R2 corrected value; (R1R2-background-R2corrected 
value)=R1 corrected value.  The corrected values for each region were averaged for each 
animal, and an overall mean and standard error was calculated across animals in each group 
for each brain region.  Means were then compared using a one way analysis of variance.  
Alpha was set at 0.05. 
RESULTS 
 The following regions were quantified: lateral septum (LS), posterolateral bed 
nucleus of the stria terminalis (BSTPL), lateral amygdala (La), and piriform cortex (Pir).  Of 
these regions (LS, BSTPL, La, Pir), no significant differences in binding were found 
(CRFR1: F(5,47)=0.76), F(5,22)=0.58, F(5,23)=0.22, F(5,23)=0.88, respectively; CRFR2: 
F(5,48)=1.09), F(5,23)=1.42, F(5,23)=0.51, F(5,23)=1.04, respectively; p>0.05).  Non-
statistical analysis of other brain sites (including periaqueductal gray (PAG) and dorsal raphe 
(DR)) revealed no differences in CRFR1 or CRFR2 binding, and no more measurements 
were recorded. 
DISCUSSION 
The current study revealed no differences in CRFR1 or CRFR2 binding between 
winners, controls, and defeated hamsters in a number of sites analyzed.  The most 
parsimonious interpretation of these data is that there are no changes in CRFR1&2 binding 
following acute defeat.  There are many references to CRF or CRF-like peptide changes 
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following various stressors (Chappell et al., 1986; Watts, 1996; Hatalski et al., 1998; Hsu et 
al., 1998; Helmreich et al., 1999; Jezova et al., 1999; Hsu et al., 2001).  On the contrary, 
there are fewer examples of changes in receptor binding (see Fuchs and Flugge, 1995).  
Although it may be that little research has been dedicated to examining binding sites for 
CRF-like peptides following stress, it is possible that this bias in the literature suggests that 
changes in peptide availability following stress are more likely to occur than are changes at 
the level of CRF receptors. 
It is also possible, of course, that CRF receptors are altered by defeat and that the 
current design did not reveal this change.  While it is possible that there were problems at the 
level of the assay performed, it is more likely that the behavioral design was not conducive to 
detecting changes.  Instead of collecting tissue at time points following the initial defeat, the 
tissue could have been collected at various time points following a 5-min CD test (exposure 
of a defeated hamster to a non-aggressive intruder).  If CRF peptide availability increases in 
defeated hamsters, increased CRF peptide release during CD testing might result in 
decreased binding of 125I-sauvagine (during autoradiography) compared to controls because 
those binding sites are already bound by endogenous CRF.   
Although it is possible that an exhaustive analysis of the autoradiography data might 
reveal an effect that has not been observed thus far, analysis was focused on limbic sites 
previously associated with defeat, particularly the BSTPL (Jasnow et al., 2004b; Cooper and 
Huhman, 2005a), and with fear conditioning (LeDoux, 2000; Blair et al., 2001; Repa et al., 
2001), as well as the LS, DR, and PAG, which is associated with defensive behavior.  The LS 
is involved in the control of agonistic behavior in hamsters (Kollack-Walker et al., 1997; 
Delville et al., 2000) and in fear conditioning (Campeau et al., 1997; Vouimba et al., 1998; 
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Desmedt et al., 1999; Vouimba et al., 1999; Radulovic et al., 2000).  The DR is also involved 
in fear circuitry and is a known site for CRF modulation of serotonin (Price et al., 1998; 
Kirby et al., 2000; Hammack et al., 2002; Thomas et al., 2003; Waselus et al., 2005).  
Finally, the PAG is important for fearful/defensive responses (Misslin, 2003; Vianna and 
Brandao, 2003; Vianna et al., 2003).  It was expected that any differences in binding between 
groups would be evident in one of these sites hypothesized to be important in CD and 
dominance/subordinance formation.  It is possible that changes may have occurred in a site 
we did not anticipate and would only be discovered during an analysis of numerous brain 
sites.  Though this may be performed at a later date, an analysis of the data at that level is 
beyond the scope of this study. 
It is more likely, however, that a change in peptide availability and not a change in 
available binding sites accounts for defeat-induced behavioral changes mediated by CRF.  
This conclusion is drawn from the fact that exogenous CRF administration enhances 
submissive behavior in suboptimally defeated hamsters.  These hamsters, when given 
vehicle, do not show CD, suggesting that changes did not occur following the previous defeat 
that could support an alteration in subsequent behavior.  However, central administration of 
ovine CRF to these hamsters before exposure to a non-aggressive intruder has dramatic 
effects on subsequent behavior (i.e., they exhibit high levels of CD).  Therefore, it appears 
that changes in binding availability may not be occurring following defeat and that increases 
in submissiveness are only observed if the quantity of available peptide increases.   
Overall, this experiment does not reflect a dead-end but a point at which we can 
reconsider potential mechanisms and ways to investigate them.  Hopefully, future 
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experiments will provide more information toward understanding the role of CRF receptors 
in agonistic behavior. 
ACKNOWLEDGEMENTS 
The authors would like to thank Kate Sharer, Miranda M. Lim, PhD., Hemanth P. 
Nair, PhD., Lorra Miller, and the Young Laboratory at Emory University for assistance and 
training in the autoradiography performed in this study.  We would also like to thank Lauren 
Zelinski, and Alisa Norvelle, for assistance with behavior and tissue staining.  CP-154,526 
was kindly provided by Dr. Michael J. Owens at Emory University, Atlanta, GA.  Support 
for this research was provided by MH62044 to KLH, xxxxxxx to LJY, and is supported in 
part by the STC program of the NSF under agreement #IBN-9876754. 
 
  
93
GENERAL DISCUSSION 
Synthesis of the Dissertation 
The goal of this project was to investigate the role of CRF type 1 and 2 receptors in 
CD and to identify neuroanatomical locations where CRF may be acting.  The first study 
showed that exogenous administration of a non-specific CRF agonist enhances the 
expression of submissive, and possibly aggressive, behavior in hamsters that have previous 
social experience.  Submissive behavior is increased in hamsters receiving suboptimal (less 
than the standard 15-min) defeat training sessions, while aggressive behavior appears to be 
increased in hamsters not previously subjected to defeat during the experiment.  The second 
study aimed to differentiate which receptor subtype, CRFR1 or CRFR2, mediates effects of 
r/hCRF on agonistic behavior by giving CRFR subtype-specific agonists before testing.  This 
study also aimed to further examine effects of CRF on aggressive behavior with additional 
control.  Further, experiments were performed to determine whether observed effects on 
submissive and aggressive behavior were specific to agonistic behavior or if they resulted 
from general increases in anxiety-like behavior.  The results of this study strongly suggest 
that CRFR1 mediates effects of CRF on agonistic behavior, that the effects are modulated by 
previous social experience, and that the effects do not appear due to increased anxiety-like 
behavior.  The third and fourth studies aimed to describe the localization of CRFR subtypes 
throughout hamster brain and to determine whether there are social experience-induced 
changes in receptor binding of a radiolabeled ligand (possibly indicating increases in binding 
availability for endogenous CRF ligands).  While we successfully mapped CRFR subtypes 
throughout the hamster brain, thereby identifying potential areas of CRFR1 activity related to 
agonistic behavior and CD, we did not see changes in receptor binding 
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following winning or losing an acute agonistic encounter compared to controls.  Though 
other possibilities for this lack of change are also proposed in study four, it is suggested that 
any changes in CRF neurotransmission are not at the level of the receptor but at the level of 
the peptide.  This possibility is supported by numerous reviews of stress-induced changes in 
CRF peptide or mRNA expression (Chappell et al., 1986; Watts, 1996; Hatalski et al., 1998; 
Hsu et al., 1998; Helmreich et al., 1999; Jezova et al., 1999; Hsu et al., 2001).   
 The most important relationship highlighted by these results is that CRFR1 activity 
enhances the expression of agonistic behavior and that this increase appears to be modulated 
by the animal’s previous social experience.  In contrast to this finding, other research in our 
laboratory has revealed a relationship between CRFR2 and submissive behavior.  
Administration of non-specific or CRFR2-specific antagonists, either ICV or directly into the 
BST, attenuate the acquisition and expression of CD while administration of a CRFR1-
specific antagonist does not (Jasnow et al., 1999; Jasnow et al., 2004b; Cooper and Huhman, 
2005a; Cooper and Huhman, 2005b).  This seeming contradiction may indeed indicate that 
CRFR1 and CRFR2 are involved in different aspects of the learning and the display of 
situation-appropriate agonistic behaviors.  Because CRFR2 antagonists reduce the acquisition 
of CD while neither CRFR1 agonists or antagonists (Jasnow et al., 1999; Cooper and 
Huhman, 2005b) affect acquisition, CRFR2 could be involved in memory formation and 
retrieval of social defeat.  CRFR1 could then be involved in the expression of specific 
agonistic behaviors after learning and retrieval have occurred.   
The idea that CRFR1 is involved in the output of behavioral responses predetermined 
by previous social experience raises questions about where and how CRFR1 is affecting the 
expression of agonistic behavior.  While it is not possible with the current data to outline 
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specific pathways and mechanisms involved, examining the distribution of CRFR1 in the 
context of the neural control of agonistic behavior suggests possible directions for further 
investigation.  The first question to address is at what point in the expression of agonistic 
behavior CRFR1 might be playing a role.  Siegel et al. (1999) proposed two classes of 
pathways involved in the “attack response” that may be applicable to this discussion.  The 
first pathway is involved in “mediating expression,” that is, acting at the level of neural 
signals necessary for carrying out motor and autonomic responses.  The second pathway is 
involved in “modulating expression,” or modulating a “threshold” for eliciting the expression 
of agonistic behavior (i.e., suppression or facilitation of behavioral output).  If CRFR1 are 
involved at the level of “mediating expression,” then blocking CRFR1 should block the 
expression of agonistic behavior.  However, this role is not likely because administration of 
the CRFR1-specific antagonist CP-154,526 does not affect CD (Jasnow et al., 1999; Cooper 
and Huhman, 2005b).  A more likely role for CRFR1 lies at the level of “modulating 
expression” of agonistic behavior by affecting “thresholds,” via some unknown pathway, 
necessary for the display of agonistic behavior.  Because oCRF (a CRFR1-specific agonist) 
increases agonistic behavior in suboptimally defeated hamsters, it is possible that the 
concomitant increase of CRFR1 activity is occurring at the level of this/these unspecified 
“threshold(s).”  By doing so, oCRF may be facilitating the attainment of a necessary 
threshold for initiating the expression of agonistic behavior.  On the other hand, CRFR1 
antagonists have no effect on the expression of submissive behavior in optimally (15-min) 
defeated hamsters.  It is possible that these hamsters have undergone changes at this 
“threshold” level or at a level downstream of this point such that CRFR1 activity is no longer 
necessary to elicit the expression of agonistic behavior.   
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Although it is not clear where CRFR1 activation is occurring to affect agonistic 
behavior, the idea that CRFR1 is modulating the expression of agonistic behavior (as 
discussed above) helps to narrow the list of potential sites of action.  According to Siegel et 
al. (1999), the location where “modulation of expression” occurs is likely to be limbic.  Of 
the limbic sites thought to be involved in aggressive and defensive behavior in hamsters, the 
LS shares reciprocal connections with the AH (the latter is considered the center of the neural 
network controlling offensive aggression in hamsters and in other species; Albert and Walsh, 
1984; Siegel et al., 1999; Delville et al., 2000) and shows increases in c-fos mRNA following 
acute defeat (Kollack-Walker and Newman, 1995; Kollack-Walker et al., 1997).  
Additionally, CRFR1 binding was observed in the LS in the current study, confirming the 
existence of CRFR1 in this structure.  Thus, the LS is a possible site of action for CRFR1 
binding in enhancing agonistic behavior.  Perhaps the LS is exerting inhibitory control on 
aggressive behavior that is enhanced by CRFR1 binding in previously defeated hamsters, 
thereby facilitating the suppression of aggressive behaviors to allow for enhanced expression 
of defensive behavior.  On the other hand, CRFR1 binding may be lower in hamsters that 
have not been defeated, thereby facilitating the expression of aggressive behavior.   
Another limbic site involved in both aggressive and defensive behaviors is the BST.  
Acutely defeated hamsters express increases in c-fos mRNA in the BST (Kollack-Walker and 
Newman, 1995; Kollack-Walker et al., 1997), which, like the LS, shares reciprocal 
connections with the AH (Delville et al., 2000).  The BST also expresses c-fos 
immunolabeling following a display of offensive aggression (specifically in the 
posteromedial division of the BST; Delville et al., 2000).  Because CRFR1 are expressed 
throughout the BST in hamster, the BST may be another possible site of CRFR1 activity 
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involved in enhancing agonistic behavior.  Presently, it is difficult to propose a mechanism 
for these actions.  However, the reciprocal connections between the BST and AH enter the 
posterior BST, and c-fos immunolabeling after offensive aggression occurs in the BSTPM 
(Delville et al., 2000).  Additionally, increases in c-fos mRNA expression following acute 
defeat occur in the BSTA.  It is therefore possible that the BSTPM and BSTA are potential 
sites of CRFR1 binding for enhancing aggressive or defensive behavior, respectively. 
It is likely that there are other possible sites of action, or different sites for particular 
aggressive and defensive behaviors, where CRFR1 activity can alter agonistic behavior in a 
modulatory fashion.  However, these hypotheses allow for continued investigation of this 
phenomenon in an effort to further examine the role of CRFR1 in the enhancement of 
agonistic behavior.   
Future Directions 
The LS is the most straightforward place to begin an investigation of other limbic 
sites that may mediate the effects of CRFR1 activation on agonistic behavior.  Similar to the 
experimental design used in the agonist studies in the current project, hamsters could be 
implanted with a guide cannula into the LV and the LS.  By injecting a CRFR1 antagonist 
(like CP-154,526) into the LS prior to ICV injection of oCRF, CRFR1 in the LS should be 
effectively blocked by the antagonist, preventing binding of oCRF.  If the LS is the site 
where CRFR1 activation is occurring to enhance agonistic behavior, enhancement should not 
occur in hamsters receiving CP-154,526.  Figure 1 of the Appendix proposes potential 
pathways that originate in the LS.   
Assuming the LS is the site of CRFR1 activation, its reciprocal connections with the 
AH would provide a pathway for the enhancement of aggressive behavior.  It is possible that 
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inhibitory control of aggressive behavior from the LS to the AH may be “turned off,” or 
inhibited, by CRFR1 activation in the LS in animals that have not been previously defeated.  
In this way, aggressive behavior is not being suppressed (and may actually be increased).  
Conversely, CRFR1 activation in a previously defeated hamster may facilitate inhibition of 
aggression through LS?AH connections, decreasing the likelihood of displaying aggressive 
behavior.  Assuming the enhancing effects of CRFR1 activity on aggressive and submissive 
behavior are occurring via the same site of action, it is possible that connections from the LS 
to the AH also activate mechanisms that initiate defensive behavior.  This idea is supported 
by the fact that c-fos mRNA increases in the AH in hamsters following acute defeat 
(Kollack-Walker and Newman, 1995; Kollack-Walker et al., 1997).  Alternatively, another 
possible pathway for activating defensive behavior could be through LS? extended 
amygdala connections.  In particular, the Ce or BSTL, both of which are involved in 
initiation of autonomic and endocrine responses to stress, may be important for activating 
defensive behavior.  As it is difficult to differentiate brain regions involved in stress 
responding from specific regions involved only in defensive behavior (Kollack-Walker and 
Newman, 1995; Kollack-Walker et al., 1997), it is likely that defensive behavior in 
submissive hamsters is modulated by the same upstream sites that are stimulating the 
accompanying stress response.  Potential candidates include Ce, BSTPL, IL, LS, and DR.  
These sites provide potential targets to further map out the circuitry controlling the effect of 
CRFR1 activation on agonistic behavior.  Finally, once it is determined to where the LS is 
projecting to affect agonistic behavior, it will be necessary to determine, on a molecular 
level, how CRFR1 binding is activating these pathways and how previous social experience 
is modulating its effects.   
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A similar experimental design to that described above could be applied to 
investigation of the BST in mediating the effects of CRFR1 activation on agonistic behavior.  
However, this approach is complicated by the fact that CRFR1 activity could be occurring in 
discreet, and possibly multiple, subdivisions of the BST to enhance the experience-
appropriate behavior.  Connections between the BSTP and AH could mediate enhancement 
of aggressive behavior in hamsters that have not been previously defeated.  If so, the 
enhancement of aggressive behavior may be blocked by CP-154,526 injection into the 
BSTPM prior to ICV injection of oCRF.  Investigating the site of action of CRFR1 activation 
on defensive (or submissive) behavior is more complicated.  Increased c-fos mRNA 
expression has been observed in the BSTA following defeat, making this site a possible 
candidate for oCRF binding.  However, because defensive behavior and stress response 
circuitry are likely overlapping, the BSTPL may be a possible site of action due to its 
connections to the stress system (Walker and Davis, 1997; Davis et al., 1997; Davis and Shi, 
1999; Lang et al., 2000).  Therefore, both the BSTPL and the BSTA (specific anterior 
subdivision unknown) are candidates for receiving CP-154,526 prior to ICV oCRF.  Figure 2 
of the Appendix proposes potential pathways that originate in the BST.  If antagonism of 
CRFR1 in one of these sites blocks enhancement of submissive behavior by oCRF in 
previously defeated hamsters, further investigation can commence as to the specific 
molecular mechanisms involved in this effect and how previous social experience modulates 
this outcome.  In the event that antagonism of CRFR1 in both BSTA and BSTPL block 
enhancement of submissive behavior, it is possible that there are connections from or 
between these two sites that are involved in the control of this effect.   
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As stated previously, these are only starting points for further investigation.  Despite 
the numerous findings of this project, an understanding of CRF enhancement of agonistic 
behavior is far from being attained.  I have essentially come a long way to know virtually 
nothing about this phenomenon, but I look forward to the challenge of one day answering 
these questions. 
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Figure A.1.  Represents potential circuitry involved in the control of agonistic behavior by 
CRFR1 in the LS.  In non-defeated hamsters, CRFR1 activity blocks the inhibitory control of 
the LS over the AH, which allows for the expression of aggressive behavior.  Conversely, in 
previously defeated hamsters, CRFR1 in the LS results in inhibition of aggressive behavior 
by inhibiting the AH.  Additionally, projections from the LS to stress circuitry (such as the 
extended amygdala and other sites) would likely mediate the effects of CRFR1 on defensive 
behavior (these projections may be direct or indirect).   
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Figure A.2.  Represents potential circuitry involved in the control of agonistic behavior by 
CRFR1 in the BST.  In previously defeated hamsters, CRFR1 activation could be occurring 
in the BSTPL, initiating stress-responsive behavior (including defensive behavior).  In non-
defeated hamsters, CRFR1 activity could be occurring in the BSTPM, and projections to the 
AH would then initiate aggressive behavior.  Another possibility for the initiation of 
agonistic behavior in defeated hamsters is that CRFR1 binding is occurring in the BSTA, 
which may have projections to the appropriate subregions of the BSTP to block aggressive 
behavior in previously defeated hamsters while indirectly activating defensive behavior via 
the BSTPL (or the BSTPL may be directly activated by concomitant binding at CRFR1 in 
that subregion). 
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